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Abstract
The purpose of this study was to investigate potential associations between psychological
flexibility (PF) and characteristics of the psychedelic experience: self-perceived meaningful
intention, feelings of comfort and safety, decentering, mystical experiences, ego-dissolution, and
insight. The first hypothesis was that perceived meaningful intention and feelings of
comfort/safety during the psychedelic experience were expected to be associated with PF,
decentering, mystical experiences, ego-dissolution, and insight. The second hypothesis was that
decentering, mystical experiences, ego-dissolution, and insight were expected to be associated
with greater PF. Participants who used classic psychedelic substances prior to this study were
recruited from social media. The sample after data cleaning was N = 427, however, following
pairwise deletions the final sample size across analyses ranged from 114 to 149. The results of
this study revealed that both self-perceived meaningful intention and feelings of comfort/safety
were associated with decentering. Comfort/safety during the experience was also associated with
mystical experiences, whereas intention was also associated with PF and insight. Although
mystical experiences, ego-dissolution, and insight were shown to be positively correlated with
PF, decentering was the only hypothesized variable associated with PF, when all characteristics
were included in the regression model. Taken together, these results suggest that deeper and
more complex relationships among characteristics of the psychedelic experience are likely to
exist with each other and with positive outcomes such as PF.
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Psychedelic Use and Psychological Flexibility
In 1956, Humphry Osmond coined the term ‘psychedelic’ in a letter to Aldous Huxley to
describe the effects produced by substances such as mescaline and LSD. This term derives from
Greek, meaning ‘mind-manifesting’ (Kaplan, 2016). The term was used by Osmond to label
psychedelic experiences because it is “clear, euphonious, and uncontaminated by other
associations” in comparison to alternative terms such as psychephoric, psycheplastic, and
deliriants (Kaplan, 2016, pg. 6). Today, classic psychedelics are defined as agonists or partial
agonist hallucinogens, which act upon the serotonin 5-hydroxytryptamine (5-HT) 2A receptors
(Nichols, 2016). They are in the class of psychoactive substances that alter perception, mood,
and a variety of other cognitive processes, which make up what is referred to as the psychedelic
experience. Specifically, the National Institute on Drug Abuse regards classic psychedelics as
those which exert effects on the 5-HT serotonin receptors: LSD (D-Lysergic acid diethylamide),
psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine), mescaline (3,4,5Trimethoxyamphetamine), DMT (N,N-Dimethyltryptamine), and Ayahuasca (a combination of
N,N-DMT and monoamine oxidase inhibitors). In addition, 5-MeO-DMT (5-Methoxy-N,Ndimethyltryptamine) has also been shown to be an agonist for the serotonin subtype receptors, 5HT1A and 5-HT2A (Davis et al., 2018).
Psychedelic use has a rich history that covers an expansive area involving
religious/spiritual ceremonies, healing, and recreation. Usage has been depicted via cave
paintings, sculptures, and writings, suggesting potential cultural influences and origins that date
back thousands of years (Akers et al., 2011; Belouin & Henningfield, 2018; El-Seedi et al., 2005;
Solecki, 1975). Research on psychedelics was particularly active from 1955 to 1970 (Kyzar et
al., 2017). This research nearly came to a halt in 1970 with the implementation of the Controlled
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Substances Act, which categorized all known psychedelics at the time as schedule one
substances. Beginning in the 1990s, with the first human research on N,N-DMT in over 20 years
(Strassman, 1994), a resurgence of interest has emerged and is being called a psychedelic
renaissance (George et al., 2021; Sessa, 2018). As examples, scientists are beginning to explore
the mechanisms of psilocybin and behavior change (Barrett et al., 2020), interaction with the
Default Mode Network (Pasquini et al., 2020), and more plastic brain states as a result of these
substances (Carhart-Harris et al., 2016). Though research has picked up, there are gaps in the
literature surrounding characteristics of the psychedelic experience that should be explored to
better understand the interaction between psychedelics and well-being. The current study will
elaborate on the role of psychedelic use, psychological flexibility, and psychological processes
such as perceived meaningful intention, feelings of comfort/safety going into and during the
experience, decentering, mystical experiences, ego-dissolution, and insight, which are expected
to be integral parts of the psychedelic experience for the benefit of those who use.
History of Psychedelic Use
Although researchers are unable to pinpoint the earliest practice of psychedelic
substances, usage has been found as early as 60,000 B.C.E (Solecki, 1975). Scientists gathered
microfossils of a substance now called ‘Ephedra’, which was found in a burial site in and outside
of a cave in modern-day northern Iraq. Links have also been made to ancient India (Wasson,
1971) and radiocarbon dating linked two mescaline-containing peyote buttons to 3780-3660 BC
(El-Seedi et al., 2005). Mescaline can be found in certain cacti (e.g., Peyote or Lophophora
Williamsii, San Pedro or Echinopsis pachanoi, Peruvian Torch or Echinopsis peruviana) and are
eaten on their own or via a tea. One of the first depictions of a psilocybin-containing substance
(found in many mushroom species; Andersson et al., 2009) was in the caves of the Tassili
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plateau in Southeastern Algeria around 5000 BCE in which a shaman was drawn holding
mushrooms. Additionally, the Selva Pascuala cave painting, dating to around 4000 BCE in
Spain, portrays a fungus similar to Psilocybe Hispanica, a psychoactive species which grows in
the nearby area (Akers et al., 2011).
Religious and Spiritual Use
These classic psychedelics have been used in a variety of different contexts including
within and outside of ceremony. Ayahuasca, for example, mostly appears to be used in
ceremonial contexts where a shaman is present and guides the session(s). A combination of N,NDMT and MAO inhibitors are made into a drink, ayahuasca, by mixing at high temperature the
leaves of the Psychotria Viridis shrub and the stem of the Banisteriopsis Caapi vine (DomínguezClavé et al., 2016). Frecska et al. (2016) described ayahuasca as being originally used by
indigenous communities and later mestizo populations. Ayahuasca as well as other plants and
fungi which have been used historically in ceremonial contexts to produce non-ordinary states of
consciousness or mystical forms of experience are referred to as entheogens (Richards, 2002;
Rochester et al., 2021). Historically, entheogens have been used in shamanic ceremonies, in
which a shaman and group consumed the substance while music (e.g., drumming, singing,
clapping) played throughout the length of the ceremony. Some goals for these shaman-led
ceremonies included guidance in diagnosing and treating disease, connection with ancestors,
acquiring information about missing family members, and enhancing well-being (Guerra-Doce,
2015). To the individuals of these cultures, entheogenic substances deserve a high level of
respect and are honored as powerful sacred medicines, facilitating connection to oneself and the
universe. Even today where knowledge of ayahuasca is spreading worldwide, it is still regarded
by many as a sacred medicine and is typically not taken recreationally or carelessly, as seen by
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ceremonial use within the Santo Daime religion and União de Vegetal (UDV) group (Balzer,
2005; Anthony Richard Henman, n.d.). Additionally, the mescaline-containing cactus, Peyote, is
also used in the Native American Church for ritual use. In fact, these substances are only allowed
to be used by these groups due to exemption via the Religious Freedom and Restoration Act of
1993.
Another psychedelic, Amanita Muscaria, is believed by some to have been used in
ancient Judaic traditions, in which Moses is seen as an entheogenic shaman as described through
encounters of the burning bush and the meeting with God on the mountain (Ruck et al., 2001).
Additionally, the ancient Greek and Celtic religions are also believed to have used Amanita
Muscaria in their religious traditions (Ruck et al. 2001). Interestingly, it is argued that both the
ancient Egyptians and Hindus used alchemy with Amanita Muscaria and potentially Psilocybe
Cubensis to achieve immortality (Heinrich, 2002).
Non-Ceremonial and Recreational Use
Psychedelic substances may have also been used outside of ceremonial contexts and for
recreational purposes, however, large gaps in the literature still remain compared to its religious
and spiritual use. One example that argues for non-ceremonial use in history can be seen with
shamans from various groups such as the Inuit and Yukagir. These individuals would eat
psychoactive mushrooms and then drink the urine of intoxicated reindeer to receive more potent
doses in order to achieve alterations in consciousness (Bogoraz, 1909).
The recreational use of classic psychedelics may be defined as consuming substances
such as LSD, psilocybin, mescaline, or N,N-DMT for casual purposes. Individuals who
participate recreationally may form a goal to have a ‘good time’, experience mystical-type
effects, or just pass the time. These individuals may also be using the substance to enhance their
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environment such as listening to and viewing a concert. Additionally, curiosity of the substance’s
effects may also be a reason for use. One psychedelic substance that has been associated with
recreational use is LSD. In 1938, Albert Hoffman first synthesized LSD-25 while looking for a
circulatory and respiratory stimulant (Hofmann, 1980). In 1943, researchers began investigating
LSD and its effects, and focus was drawn to the potential therapeutic use in psychotherapy.
Unger (1963) wrote that the use of LSD in multiple doses helps the patient remember and abreact
both recent and childhood traumatic experiences, speak about these traumatic experiences more
easily, and allow the patient to better see their defenses to these experiences and alter them in a
beneficial manner. However, although the use of LSD may have begun as more of a medical
treatment when it was first being researched, it quickly gained popularity in the public for
recreational use and is now often associated with the ‘hippie counterculture’ of the 1960s where
the ideal was love and peace, encompassing the opposition of war, and being in favor of mindexpanding drugs (Poon, 2016).
Modern Trends of Use
In 2019, the National Survey on Drug Use and Health was conducted by the Substance
Abuse and Mental Health Services Administration and data indicated that approximately six
million individuals 12 or older used hallucinogens at some point in their lives. Ages 18-25 show
the highest reported use of hallucinogens for 2019 with 7.2 million. The two most frequently
used psychedelics were psilocybin and LSD.
Presently, most psychedelics are classified under schedule one according to the DEA
(Drug Enforcement Agency); substances classified as schedule one drugs have no accepted
medical use and have a high potential for abuse. They are also banned from being used in
research unless approved by a government agency such as the DEA or FDA (Nutt et al., 2013).
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Over the years, there have been exceptions made by government agencies with funding through
private donors, in which findings have garnered growing interests in the therapeutic potential of
psychedelics. Barnett et al (2022) investigated NIH grants that were given from 2006-2020 and
found no direct funding of clinical trials for psychedelic-assisted therapy, however in 2021, the
NIH awarded its first grant in 50 years to John Hopkins Medicine to investigate the use of
psilocybin on tobacco addiction.
Krebs & Johansen (2013) analyzed data from the National Survey on Drug Use and
Health from 2001 to 2004 with a representative sample of approximately 130,000 U.S. civilian
non-institutionalized adult respondents aged 18 and older and results not only suggested no
evidence for the addictive potential of LSD, psilocybin, or mescaline, but also no evidence that
past use exacerbated mental health issues. For many psychedelic users, the researchers found that
after use, there were reduced rates of mental health issues. As examples, females had lower rates
of the psychotic symptom “felt force taking over mind”, younger individuals had lower rates of
generalized anxiety disorder (GAD), and older individuals had lower rates of psychiatric
medications. Additionally, among psychedelic users with reported illicit drug use, there were
lower rates of inpatient mental health treatment, needed mental health treatment, symptoms of
GAD, agoraphobia, and PTSD. It should be noted that there are contraindications of use for
certain people such as personal or family history of psychosis or bipolar disorder, as well as
those with hypertension (Nutt & Carhart-Harris, 2021). Additionally, certain medications (e.g.,
amitriptyline, trazodone) and serotonin reuptake inhibitors are required to be stopped or reduced
for a certain period of time prior to use as they can be dangerous to the user (Nutt & CarhartHarris, 2021). However, for healthy individuals, use is generally safe (Nichols, 2016).
Classic Psychedelic Effects and their Neural Underpinnings

Psychedelic Use and Psychological Flexibility

7

While under the influence of psychedelics, individuals have reported effects such as
hearing sounds and seeing images that are not actually there (e.g., faces, geometric patterns;
Bressloff et al., 2002; Kometer & Vollenweider, 2016), as well as synesthesia, the combination
of certain senses (i.e., smelling color, seeing sound; Luke & Terhune, 2013). Reports also
indicate acuity enhancement (i.e., focused/sharper field of view on the environment), color
shifting (Kleinman et al., 1977), and visual drifting (i.e., objects flowing, morphing,
breathing/contracting inwards and expanding outwards, melting/drooping; Kleinman et al., 1977;
Muthukumaraswamy et al., 2013). In one example, the effects of N,N-DMT and 5-MeO-DMT
were explored. Although 5-MeO-DMT is found in various plants as well as in high
concentrations in the Bufo alvarius toad venom (Davis et al., 2018), both of these substances can
be synthesized and inhaled to produce intense and short psychedelic experiences. These intense
and short psychedelic experiences usually begin immediately after inhalation and peak within a
few minutes, with individuals returning to baseline around 30 minutes (Strassman et al., 1994).
Gouzoulis-Mayfrank et al. (2005) reported some of the subjective effects of DMT to be visionary
reconstructuralization (i.e., surroundings rapidly shift in space/time perception, vivid
visualizations of fractals or geometric patterns), oceanic boundlessness, and anxious egodissolution. In contrast with inhalation, the subjective effects of the tea, ayahuasca, can last from
four to 12 hours, whereas LSD generally lasts from eight to 12 hours (Barbosa et al., 2009;
Rothlin, 1957).
In addition, studies have shown that many participants have reported beneficial changes
to their personality following use such as increases in openness and trend-level increases in
conscientiousness (Erritzoe et al., 2019; Erritzoe et al., 2018). Openness can be defined as
putting aside any beliefs one already holds while being tolerant to novel viewpoints in addition
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to aesthetic appreciation and willingness to have new experiences, which may be outside of
one’s norm (Baehr, Maclean et al., 2011). Erritzoe et al. (2019) investigated psychedelic- and
MDMA-preferring users in addition to a non-using control group; findings revealed that
participants who used psychedelics scored significantly greater than the other two groups on the
measure of openness. Conscientiousness encompasses responsibility, organization, taking
obligations to others seriously, and being hard working (Roberts et al., 2014). In another study
by Erritzoe et al. (2018), treatment-resistant depression patients were given psilocybin during
two, one-week separated sessions and results found significant increases in openness and trendlevel increases in conscientiousness up to three months following the sessions. Use has also
produced profound changes to a user’s state of consciousness such as ego-dissolution (i.e., loss
of sense of self, oceanic boundlessness; Nour et al., 2016) as well as improved psycho-social
functioning (e.g., attitudes about life, self, mood changes, social effects, behavior change,
increased spirituality) four months following a psilocybin clinical session (Smigielski et al.,
2019).
Although reports of mystical-type experiences and beneficial changes to well-being are
reported by users of classic psychedelic substances, the neural underpinnings for how and why
these experiences and positive changes occur are still being investigated. In a 2015 study,
Kometer et al. assessed 50 healthy individuals using electroencephalogram (EEG) and found that
psilocybin was able to slow down neural oscillations in the anterior and posterior cingulate
cortices and the parahippocampal regions. These regions serve important functions in memory
retrieval and emotion, as well as self-reflection, which occur for many people during psychedelic
sessions. Decreasing the speed of neuronal oscillations can possibly facilitate increases in
mystical experiences and potentially insightfulness by giving the user the ability to self-reflect to
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a greater depth and perhaps from another point of view than what would not be possible without
psychedelic use. The researchers concluded that decreases in specific spatiotemporal neural
mechanisms were linked to mystical experiences and increases in insight. Not only have
participants from other studies reported increases in connectedness, insight, and well-being
(Davis et al., 2021; Forstmann et al., 2020; Spriggs et al., 2020), but brain-imaging suggests that
while under the influence of psychedelics the brain becomes more plastic or flexible, allowing
for greater openness to experience and what follows might be increases in positive behavior
change (Carhart-Harris & Goodwin, 2017; Carhart-Harris et al., 2016).
The entropic brain hypothesis or REBUS (Relaxed Beliefs Under Psychedelics; CarhartHarris & Friston, 2019) holds that while under the effects of psychedelics, an individual’s priors
(i.e., past experiences) and beliefs are relaxed to an extent that thoughts and visual memories can
flow easier, allowing individuals to come face-to-face with experiences and emotions that
previously may have been caught in ruminating patterns of judgment (Carhart-Harris & Friston,
2019). A more recent construct, called the pivotal mental state (Brouwer & Carhart-Harris,
2021), is currently being investigated as a mediator for psychological transformations. The
pivotal mental state is defined as a transient and intense hyper-plastic state in which rapid
learning occurs during the psychedelic experience by way of increased neuroplasticity (i.e., the
brain’s ability to change or reorganize for increased adaptability to novel experiences; Demarin,
2014) and associative learning (Brouwer & Carhart-Harris, 2021). Pivotal mental states can be
divergent and lead to either positive or negative outcomes, therefore context and intention are
important aspects of this mental state and are being further investigated to understand types of
set (i.e., mindset, comfortability, readiness for the psychedelic experience) and settings (i.e.,
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external environment such as home, alone, with friends, weather) predictive of improvements for
an individual’s well-being.
Research has focused on classic psychedelic agonism of the 5-HT2A serotonin receptors
as the primary pathway of effects (Aghajanian, 1999; Contreras et al., 2021; López-Giménez &
González-Maeso, 2017) and it is proposed that these substances, by inducing pivotal mental
states, can mediate psychological transformation. Additionally, research has revealed that
psychedelics increase the release of stress hormones such as cortisol and oxytocin (Strajhar et al.,
2016; Schmid et al., 2015), suggesting that the psychedelic-induced state of consciousness can be
perceived as intense or emotional to the user, and may be an underlying mechanism for
psychological transformation. Roseman et al. (2019) revealed that following psychedelic
therapy, emotional breakthroughs mediate long-term improvements to individual well-being.
Mystical experiences were also a predictor of increased well-being during the experience,
suggesting that the mystical experience may serve a pivotal role of self-reflection by which rapid
learning of pivotal mental states occur, along with emotional breakthroughs.
In a study on PTSD, Inserra (2018) proposed that ayahuasca is able to retrieve traumatic
or challenging life experiences via our sigma 1 (endoplasmic reticulum proteins) stressresponsive receptors and the MAOIs present within the brew. Through increased synaptic
plasticity, neurogenesis, neurotransmission, as well as the modification and reconsolidation of
traumatic or challenging experiences, fear responses to these experiences can be changed or
removed, suggesting healing potential for individuals with PTSD. With the use of fMRI, another
psychedelic substance, LSD, has been shown to increase global connectivity and communication
in the brain through the bilateral thalamus as well as the frontal, parietal, and inferior temporal
cortices, which is mediated by significant overlaps with the serotonin 5-HT2A receptors
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(Tagliazucchi et al., 2016). These increases of global connectivity were revealed to be positively
correlated with psychedelic users’ reports of ego-dissolution, or loss of the sense of self (Girn et
al., 2020).
Classic psychedelics have also been shown to decrease functioning of the Default Mode
Network (DMN), which is comprised of a set of brain regions (posterior cingulate cortex,
precuneus, medial prefrontal cortex, inferior parietal cortices; Broyd et al., 2009) believed to be
more active during restful states, such as during meditation, self-reflection, and memory retrieval
compared to more active cognitive task performance states (Ekhtiari, 2016; Palhano-Fontes et
al., 2015; Pasquini et al., 2020). It is proposed that the decrease of the DMN allows patterned
thoughts and rumination common in depression and anxiety to be reduced and facilitate the
psychedelic user to be able to self-reflect on their thoughts and emotions much more effectively,
without judgment or reactivity. The DMN may also be important for the sense of self in addition
to self-processing (Davey et al., 2016; Vessel et al., 2013).
The aforementioned neural underpinnings of how certain psychedelics are proposed to
work within the brain can be extended to psychological changes in users. In a study by Barrett et
al. (2020), 12 participants consumed 25mg (dose)/70kg (body weight) of psilocybin. Results
revealed that positive affect, dorsal lateral prefrontal, and medial orbitofrontal cortex responses
to emotionally-conflicting stimuli (presented through fMRI emotion-processing tasks) were still
increased one month following psilocybin use. Griffiths et al. (2011) investigated psilocybin use
for 18 participants, 17 of which were psychedelic naïve (i.e., an individual who has never used a
psychedelic substance), and found that most participants reported increased positive well-being
(e.g., increased mood, attitudes, behavior change), even 14 months following use. However, not
everyone has a positive first experience. One participant in particular, who also scored lowest on
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mystical experiences, explained to the researchers that her experience was the worst to ever
unfold in her life. The researchers hypothesized that this was likely due to a psychological
struggle of non-acceptance during the session (i.e., resistance against the psychological or
physical effects of the experience, resistance against challenging thoughts or emotions that arise),
as common effects of a large dose can be intense mystical experiences in which individuals
report being outside of space/time as well as the dissolution or complete loss of a sense of self.
Inability to let go during the experience and accept what is occurring can signify a less likely
chance for the participant to self-reflect deeply and obtain insight from their mystical
experiences. When assessed weeks later in retrospect, the researchers found that the participant
began to take positive ‘lessons’ from that session and the participant reported the experience as
having slight spiritual significance as well as increased well-being and life satisfaction. Upon
another session of 20mg (dose)/70kg (body weight), the participant reported the more recent
experience to be the most meaningful and spiritually significant experience of her life.
Challenging experiences may be a common occurrence of the psychedelic experience,
especially at larger doses, as it can bring up painful experiences or thoughts and emotions being
pushed aside for the user. However, it is important to note that challenging experiences have
been found to be associated with increased well-being over time (Barrett et al., 2017; Carbonaro
et al., 2016), suggesting that time or integration following a psychedelic session can be useful in
processing any thoughts, emotions, or mystical experiences that arose during the session.
Classic psychedelics have been shown to produce effects such as mystical experiences,
ego-dissolution, insight, and psychological flexibility, but a large gap in the literature still
remains on specific neural and psychological pathways that lead to these experiences and should
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continue to be investigated. The current project focuses on associations between psychological
flexibility and characteristics of the psychedelic experience as outlined below.
Psychological Flexibility and Hypothesized Predictors
Psychological Flexibility
Psychological flexibility (PF), sometimes referred to as cognitive flexibility, is defined as
processes and behaviors linked with being “open, aware, and active” (Vlaeyen, 2014, p. 235) and
has been shown to be positively associated with greater health and well-being. According to
Calabrese II (1994) and Kashdan & Rottenberg (2010), PF consists of multiple facets: executive
control, or self-regulation, default mental states, and personality traits. Executive control
involves a more conscious awareness of thoughts and behavior in comparison to default tasks or
habits such as driving the same route or completing the same work tasks on a consistent basis, in
order to achieve goals (Miller and Wallis, 2009). By being consciously aware and having a sense
of control over situations or challenging experiences encountered in day-to-day life, individuals
high in PF may be able to quickly adapt to situations and experiences that might have otherwise
slowed them down. Also, executive shifting in awareness or attention and control over situations
might allow for these individuals to perceive multiple explanations or solutions for life events, as
well as alter behavior to attain goals (Fleeson, 2001; Goldberg, 2001; Kashdan & Rottenberg,
2010). Additionally, acceptance and openness towards events that occur in day-to-day life are
two important factors of executive function, which have been suggested to be predictors of PF
(Shapiro et al., 2004).
The second facet of PF is the importance of default states. Kashdan & Rottenberg (2010)
state that habits and stereotypes are shortcuts for making quick decisions on how to behave
towards new people as well as how to go about well-practiced activities that do not require much
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conscious focus (e.g., brushing teeth). Despite any benefits, problems do arise when these
processes become solidified (Kammrath & Scholer, 2007) and individuals begin to overextend or
oversimplify stereotypes, as well as not focus on changing formed habits, some of which may be
detrimental to well-being (e.g., drug abuse). Individuals high in PF are likely to have the ability
to be mindful of stereotypes they may have about others, as well as awareness of their habits,
potentially altering them to improve oneself. This conscious awareness helps reduce or prevent
misjudgments about others as well as enhance creativity, engagement, and compassionate
communication (Kashdan & Rottenberg, 2010).
The third facet of PF is personality traits, such as being low in neuroticism and high in
openness (Kashdan & Rottenberg, 2010). Neuroticism has been shown to predict lower scores of
well-being as well as poor mental and physical health (Friedman, 2019; Karademas, 2007; Zhang
et al., 2021); individuals high on neuroticism are also less likely to alter their behavior (Watson,
1967), compared to those low on neuroticism. On the other hand, individuals high in PF are also
more likely to be open to new experiences, thoughts, emotions, and sensations, which may be
either positive or challenging (Kashdan & Silvia, 2009). Additionally, these individuals might be
able to challenge their own thoughts and beliefs with new information, assisting in self-reflection
and new experiences.
On the opposite end of PF exists psychological inflexibility (PI), which is apparent when
an individual maintains a certain set of dysfunctional ideals or rules for themself or is in a pattern
of thought that results in negative impacts on their life; in fact, PI has been shown to be
associated with psychopathology (Hayes et al., 2006). PI is when an individual’s experiences and
behaviors tend to lean towards experiential avoidance and cognitive fusion (Sabucedo, 2017).
Experiential avoidance contrasts acceptance and is a process by which an individual tries to
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avoid any life experiences that may be perceived as traumatic or too difficult to handle. These
experiences can come in the form of thoughts, emotions, or sensations. Hayes (2002) found that
as more of these types of experiences are avoided, the more they tend to occur, leading to
increases in psychological suffering. Cognitive fusion occurs when an individual’s thoughts and
emotions have too much control over their conceptualized self and behavior, which may result in
detrimental psychological effects such as obsessive patterns or hyper-responsibility (Sabucedo,
2017; Hayes & Pankey, 2002). As an example, participants high in inflexibility may be more
likely to place responsibility on something or someone other than themself for problems they
face, however they will not change their behavior to solve the problems. It is these inflexible
thoughts and actions that can serve as a barrier for the individual to engage in behaviors that
promote positive and/or beneficial health outcomes. On the other hand, cognitive defusion is the
process of creating a space between detrimental thoughts and emotions such as constant
repetition that oneself is anxious or depressed (Hayes et al., 2016). Interestingly, this created
space is similar to the process of decentering during the psychedelic experience in which the self
and one’s negative thoughts/emotions are separated, thus individuals can understand they are
only temporary processes of the mind and are not realities.
With the proper use of classic psychedelics in therapeutic settings, cognitive defusion in
addition to acceptance of one’s thoughts and emotions are likely to be part of the psychedelic
experience, subsequently allowing the user to come face-to-face with thoughts, emotions, and
mystical-type experiences that arise during the psychedelic session(s) for self-reflection (Adams,
2010). In a semi-structured interview study by Watts et al. (2017), patients reported that contrary
to the feelings of disconnection and avoidance felt from depression treatment medications, the
use of psilocybin (even six months following use) enhanced their sense of connection to the self,
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others, and the world, in addition to their acceptance of emotions. These patients also mentioned
that talk-therapy alone did not seem to help, which is not surprising as the patients were
treatment resistant. However, a proper combination of the appropriate use of psychedelics (e.g.,
with a guide, self-perceived meaningful intention, set and setting) and psychedelic-assisted
psychotherapy may help individuals separate from negative thoughts and emotions, thus
allowing therapy to step in and begin or continue to mold positive thinking, self-reflection, and
beneficial behavior changes (Teixeira et al. 2021; Watts et al. 2017).
One type of psychedelic-assisted therapy is Acceptance and Commitment therapy (ACT;
Guss et al., 2020; Sloshower et al., 2020) which uses the psychological flexibility model (PFM;
Watts & Luoma, 2020). The goal of ACT is to increase PF through components of the PFM:
acceptance, cognitive defusion, being in the moment, self as context (i.e., awareness of
experiences without being attached to them), values (i.e., determining what is important in one’s
life), and committed action (i.e., taking action towards one’s values; Hayes et al., 2006).
Interestingly, a study by Lin et al. (2017) explored participants with chronic pain who enrolled in
an ACT research protocol and found that PF mediated improvements to pain, depression,
anxiety, and mental and physical health. This finding suggests that ACT using the PF model
could be useful for patients in treating various health conditions. This ACT approach is likely to
be used in more psychedelic-assisted psychotherapy sessions in combination with psychological
models to maximize treatment to patients.
As an example of the efficacy when psychedelics are combined with psychological
support before, during, and following a session, one can look at the study conducted by CarhartHarris et al. (2016). Twelve treatment-resistant depression patients were given psilocybin during
two sessions and results revealed that at one-week post-session, eight of the patients had
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complete remission. At the final check-in at three months, five patients were still in complete
remission, while seven patients still showed a 50% reduction in depression symptoms compared
to baseline. Another study by Close et al. (2020) investigated PF one week prior to a psychedelic
experience as well as two and four weeks following. Results indicated significant increases to PF
up to four weeks, especially for participants who scored low on PF at baseline. Decreased
depressive scores were also found. Additionally, emotional breakthroughs and mystical
experiences were linked to increased PF.
For both of these studies, certain characteristics of the psychedelic experience such as
perceived meaningful intention and decentering were not assessed. Recent studies have shown
increases to PF and quality of life with psychedelics such as ayahuasca and LSD (Carhart-Harris
et al., 2016; Jiménez-Garrido et al., 2020); however, gaps still remain on whether characteristics
of the psychedelic experience, when grouped together, are associated with PF. Additionally, it is
important to understand which characteristics are associated with each other.
It could be that feeling comfortable and safe while receiving psychological support
allowed participants to ‘go with the flow’ of the experience, which may have included
detachment from one's thoughts and emotions, a mystical experience, and perhaps egodissolution where there is a sense of separation from the self and feelings of universal
connectedness (Carhart-Harris et al., 2017). It is likely that participants also received insight,
which may revolve around how they view themselves, their experiences, and the world. These
characteristics of the experience likely led to increases of PF following the experience, allowing
modifications in the ways participants perceive their thoughts and emotions, and thus decreases
in depression.
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Due to limited research, it is unclear what characteristics of the psychedelic experience
are associated with PF; however, some evidence points to intention, feelings of comfort/safety,
decentering, mystical experiences, ego-dissolution, and insight. Thus, the primary aim of this
study was to examine these psychological processes, or characteristics of the psychedelic
experience, as potential predictors of PF in classic psychedelic experienced participants.
Intention and Feelings of Comfort/Safety
As both intention and feelings of comfort/safety fall under the umbrella term of set and
setting, or context (Carhart-Harris et al., 2018), they will be discussed together in this section.
Set and setting has been defined as the internal and external contextual factors that go along with
psychedelic use (Gukasyan & Nayak, 2021). Set refers to one’s mindset, which may include
thoughts, feelings, emotions, a sense of preparedness, intentions, expectations, or other
psychological factors brought into the psychedelic experience. Setting refers to one’s external
environment of the psychedelic experience such as the experience occurring at home, a beach,
party, forest, while hiking, in a clinical environment, or even the type of weather (i.e., sunny,
rainy, cold, warm; Carhart-Harris et al., 2018).
Whether psychedelics are used within clinical or naturalistic environments, the set
component of set and setting may be critical for how users approach a psychedelic session and
can also affect one’s choice of setting or vice-versa. For example, some individuals may have a
more recreational approach to a psychedelic session when using LSD or psilocybin, and prefer to
have the experience take place at a concert with friends. The same individual or others may
approach a session with a more therapeutic approach, thus preferring to have a setting that is
more quiet, being alone or with those the individual is close to or with a clinician or “guide”.
One important aspect of set that may impact PF is the formation of meaningful intentions.
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Setting an intention for a psychedelic experience generally involves forming defined goals or
hopes perceived as meaningful to the user prior to the experience occurring. These goals and
hopes may be useful during the experience in that the individual knows the reasons for taking
part. If they are faced with challenging experiences or thoughts and emotions, they might have
an easier time letting go and allowing the session to flow without resistance. In turn, these
individuals may receive insight into their life that enhances PF, allowing greater adaptability in
day-to-day life following the session(s) as well as being able to perceive various explanations
and solutions for situations. It should be noted that meaningful intentions are not limited to
clinical environments, and may also be beneficial in naturalistic settings for improvements to
well-being (Healy et al., 2021).
A recent study conducted by Bathje et al. (2021) investigated the potential effects of
intention via interviews for an ayahuasca ceremony with the majority of participants being
psychedelic experienced (e.g., ayahuasca, psilocybin, LSD). Results revealed that the majority of
participants experienced ayahuasca with specific therapeutic intentions in mind (e.g., improve
relationships and connection with oneself and others, improve mental health, learn more about
the self, spiritual growth, enhance creativity). Significant improvements for participants were
reported in similar areas as their intentions, including mental and physical health, substance use,
self-care, perspective on oneself and the world, spirituality, connection, and creativity. These
findings are interesting and suggest that intention may play a large role in how the experience
flows, the thoughts and emotions that may arise, and improvements to PF.
Despite specific intentions and feelings of fulfillment, some participants did report that
their intentions were fulfilled indirectly. For example, one participant reported an intention to
improve the relationship with her child, and ended up learning more about how to process her
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own thoughts and emotions, which facilitated a higher quality relationship with her child.
Interestingly, these findings indicate that intentions and other characteristics of the psychedelic
experience specifically target how one views their sense of self as well as how they view others
and the world. As a result of this experience, this individual was made aware of their own
feelings with the self that had previously gone unnoticed. It is important to note that a component
of PF is being aware, whether this is awareness of others, or one’s thoughts and emotions with
the self. It may be that therapeutic intentions assist the facilitation of PF by allowing users to
become more aware of the self, thus affecting shifts in perceptions of thoughts, emotions, and
how they behave in various situations. Following the experience, these individuals might also be
likely to be more open in how situations are understood, and perhaps perceive and provide
explanations for certain situations, such as those having to do with romantic relationships or life
goals. Additionally, intentions based on therapeutic outcomes such as a desire to improve or heal
oneself are associated with reduced psychopathology and reduced substance use disorders
including alcohol, tobacco, opioid, stimulant, and cannabis misuse. (Winstock, 2021; GarciaRomeu et al., 2020; Johnson et al., 2017).
Of note, the labels “intention” and “expectation” are often used interchangeably, however
they may be better investigated as distinct constructs, as the psychedelic experience is difficult to
predict due to its subjective effects (Alpert, Leary, and Metzner, 1964). As shown in the study by
Bathje et al. (2021), some participant outcomes were not directly related to their intention.
Whereas intentions may set a goal for the experience, there is space generally left for unpredicted
thoughts, emotions, and behaviors to arise. Although behavioral expectations have been shown
to be a predictor of self-reported performance improvements (Warshaw & Davis, 1985),
expectations for a psychedelic experience may be too rigid, and bring along effects not predictive
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of PF, such as disappointment when the expectations are not met. During the experience,
individuals who set expectations may also be resistant to accepting and processing challenging
thoughts and emotions that come up, as the thoughts and emotions are outside any expectations
of the experience that were formed. Subsequently, the experience may not be able to ‘flow’, thus
pushing aside any insights that may have otherwise been perceived. Despite any potential
distinctions in the two constructs, it might be that both intention and expectation lie on a
spectrum, where disappointment can be an outcome for either. Large gaps in the literature still
remain on how expectation and intention differentiate in predicting PF, well-being, and
disappointment with the use of psychedelics, and should be further investigated.
On the other side of set and setting, is the setting component. As previously stated, the
setting of one’s experience refers to the external environment of where the experience is taking
place. One aspect of setting is feelings of comfort/safety. For example, an individual who uses a
psychedelic such as psilocybin at a friend’s home with others they do not know may feel they are
unable to be their authentic self during the psychedelic experience, which may result in
reductions to their sense of comfortability. On the other hand, an individual who uses psilocybin
with a guide who has reassured them to focus on the experience and assists when the user asks
for help is likely to feel safe and therefore more comfortable during the experience. In a study by
Carhart-Harris et al. (2016), treatment-resistant depression patients received psilocybin in an
environment that aimed to make the patient feel comfortable, however the variable was not
analyzed. To current knowledge, no studies have assessed feelings of comfort and safety in
relation to other characteristics of the psychedelic experience (e.g., perceived meaningful
intention, decentering, mystical experiences, ego-dissolution, PF).
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Set and setting are very important to keep in mind for clinical, spiritual, or recreational
purposes. If an individual approaches a psychedelic session with a more therapeutic intention,
and chooses to use psilocybin, for example, at a concert or in an area where they may feel they
cannot be themself, their feelings of comfort and safety may go down. Low comfort and safety
may not allow individuals to go with the ‘flow’, or surrender to the experience because the
participant might feel they have to watch over their own safety. It is likely that for these
individuals, they will be resistant to characteristics of the psychedelic experience that involve
separating from one’s thoughts and emotions, the sense of self, as well as ego-dissolution. As a
result of this resistance, challenging experiences can come up, and thus the user may be less
likely to receive insight during the experience. It is important to note, however, that even
challenging experiences can have benefits for well-being over time, as previously mentioned
(Barrett et al., 2017; Carbonaro et al., 2016).
Individuals who set a therapeutic intention for the experience and use the psychedelic in a
setting in which they can be themself and feel both comfortable and safe might be more likely to
surrender to thoughts and emotions brought up. These individuals might also be more likely to
allow a separation from their sense of self, such as ego-dissolution. Feelings of comfort/safety
might predict PF, as users can experience thoughts, emotions, feelings of bliss, connectedness,
and other characteristics of the psychedelic experience without or with reduced resistance that
would have likely not occurred if the user did not surrender. A study by Haijen et al. (2018)
revealed a marginally significant positive association between greater scores on preparedness or
readiness for the psychedelic experience and fewer challenging experiences. Preparedness and
readiness may be components derived from an individual’s set and setting, suggesting that
intention and feelings of comfort/safety may be critical to how other characteristics of the
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psychedelic experience are appraised, and also whether or not any insights are perceived. Gaps in
the literature still remain in connecting feelings of comfort/safety to PF. Although clinical studies
generally focus on a setting that may be perceived as appropriate to a therapeutic psychedelic
session (i.e., lights dimmed low, music played over high-quality speakers), these studies did not
investigate how the setting may have impacted PF (Carhart-Harris et al., 2016; Murphy-Beiner &
Soar, 2020; Palhano-Fontes et al., 2018; R. R. Griffiths et al., 2011).
Perceived meaningful intention along with feelings of comfort/safety may serve an
important role in preparing for the psychedelic session, when characteristics of the experience,
such as decentering, mystical experiences, and ego-dissolution, begin to arise. These experiences
are also predicted to have a positive effect on PF.
Decentering
Decentering has been defined as the ability to detach from the self and recognize thoughts
and emotions as temporary of the mind (Fresco et al., 2007). In other words, this process allows
a space, or a disconnect, to be formed between an individual’s sense of self and any thoughts or
emotions that arise during the experience. Instead of these thoughts and emotions perceived as
facts and solidified, they are understood as only being temporary and deriving from a limited
perspective (Kerr et al., 2011). It may be that decentering serves a critical role in the process of
self-reflection and may predict PF through cognitive reappraisal, which occurs when an
individual is able to change the meaning of experiences by re-evaluating their emotions towards
the event (Gross & John, 2003). Given that individuals feel comfortable and safe during the
psychedelic experience, they may be more likely to surrender to any thoughts or emotions that
come up and perceive them from another perspective, which allows learning and understanding
to take place, thus potential insight. Individuals who are able to decenter and properly self-reflect
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during the psychedelic experience may be more likely to understand the reasons why they feel a
certain way towards themselves, others, and their behaviors (Grant, 2001).
Self-reflection during decentering seems to be in opposition to rumination, which has
been defined as focusing on the symptoms of one’s problems as well as its causes and outcomes
without actually taking any action or being unable to ‘escape’ that mode of thinking (NolenHoeksema et al., 2008). As an example, an individual may tend to self-reflect on certain
problems in their life such as why they are unhappy in their career or where they currently are in
their life. Rumination of these thoughts would be similar to a cycle where one thinks about the
problem, its causes, and how it is making them feel the way they do. Decentering separates the
individual from these thoughts and allows them to feel these emotions from a different
perspective, where instead of the constant focus on the problems the way it is usually
understood, the individual can perceive alternative explanations for why they feel a particular
way.
It should be noted that experience with psychedelics may be an important factor in
determining how well an individual is able to separate from their sense of self during the
experience. In a study by Franquesa et al. (2018), decentering was investigated in two groups:
participants who have had previous experience with ayahuasca and those who have not. Results
revealed that participants with prior ayahuasca experience were able to decenter more during the
experience compared to the non-experienced group. Additionally, the ayahuasca group was split
into a sub-sample of those who had used it more than 15 times and those with fewer than 15
sessions. Again, results revealed greater decentering for the more experienced group, suggesting
that familiarity may play a role in the strength by which individuals are able to separate their
thoughts and emotions from their sense of self. Reasoning for this finding may be that the more
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familiar one gets with separating their sense of self from thoughts and emotions, the more they
understand when this process is occurring so that they can welcome and not resist against
perceiving alternative explanations for their thoughts, emotions, and behavior. Decentering may
serve as a predictor for PF, allowing individuals to perceive multiple explanations and solutions
for day-to-day life events and challenges without getting caught in a loop of patterned thinking.
Mystical Experiences
Mystical-type experiences are commonly-reported subjective effects of psychedelic
substances, which may encompass the sense of internal and external unity or connection, noetic
quality (i.e., the experience serves as objective truth), sacredness, bliss, peace, love, distortions in
space/time, and the formation of hallucinations (Griffiths et al., 2018, 2006; Barrett et al., 2015).
It could be that mystical experiences supplement the process of decentering, allowing a more
immersive (i.e., visual, auditory) experience by which individuals are able to perceive their
thoughts and emotions from other points of view. Kaelen et al. (2018) and Davis et al. (2020)
suggest that mystical experiences may be predictive of PF, due to an acceptance and perhaps
release of emotions (MacLean et al., 2011), however more research is needed to fill the gap that
mystical experiences lead to PF. It is important to note that clinical trials are finding mystical
experiences to be an important component of the therapeutic use of psychedelics, which lead to
reductions in depression, anxiety, and improvements to well-being (Garcia-Romeu et al., 2015;
R. R. Griffiths et al., 2016). Davis et al. (2020) found that increased PF mediated the effect of
mystical and insightful experiences on reductions in depression and anxiety in a sample of adults
who have reported using a psychedelic. These findings are very interesting and suggest that
mystical experience plays a role in PF, likely through the changes in perspective of one’s
thoughts and emotions as well as the receival of insight. Additionally, the positive emotions that
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tend to comprise the mystical experience such as a sense of universal connection, peace, bliss,
love, sacredness, and noetic quality may also be contributing factors in predicting PF.
Ego-Dissolution
Ego-dissolution might be viewed as an experience of self-awareness (Letheby & Gerrans,
2017), where a user’s ego-boundaries (i.e., concept of self) dissolves and the user reports a
significant or complete loss of self, oftentimes also experiencing a deep sense of universal
connection (Nour et al., 2016). The self comprises all things that make up who we are as a
person, such as experiences, thoughts, emotions, and actions (Asai et al., 2016). During the
process of ego-dissolution, which is suggested to occur during mystical states, all that defines us
is stripped away and we are left with just an awareness without a sense of self (Letheby &
Gerrans, 2017). There are large gaps in the literature that remain on how exactly ego-dissolution
operates, however it could be that partial to complete separation from everything which defines
us allows individuals a perspective of awareness and insight that is otherwise likely to not be
experienced elsewhere.
In a similar line of work, tying together other research, Piff et al. (2015) found that
experiences of awe influenced participants to sense that there was something larger than the self,
and subsequently reduced participants’ self-interests and tendencies to solely focus on the self.
These participants reported feelings of being small, or insignificant, due to their experiences of
awe; thoughts, emotions, and concerns of the self were unimportant in the ‘grand scheme of
things’. Additionally, it was found that participants high in awe increased their prosocial
behavior, as well as reported increases in being generous and ethical. Ego-dissolution is likely to
facilitate significant increases to awe in psychedelic users through complete separation from the
self and a sense of universal connection (Letheby & Gerrans, 2017), therefore allowing them to
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understand that their concerns, self-interests, and tendencies to be focused on the self are
unimportant. Nour et al. (2017) suggested that ego-dissolution allows individuals the opportunity
to understand and accept that all we know about reality is limited and socially determined,
extending to reductions in individuals to center around the self, or ego. These findings indicate
that ego-dissolution during psychedelic experiences may lead to increased PF by not only
enhancing connection with oneself, others, and the world, but also allowing adaptations to dayto-day events, facilitating individuals to perceive multiple explanations or solutions to their
experiences, thoughts, and emotions.
Insight
Insight is a characteristic of psychedelic use that may come about as a result of one’s
intention, decentering, mystical experiences, and ego-dissolution. Some examples of insight
provided by Davis et al. (2021) include realizations about maladaptive ways of coping (e.g.,
smoking, drinking, overeating), clarity in the direction to move one’s career and actions to take,
being more empathetic towards others and taking their feelings into account (e.g., partner, child,
friend), and understanding that particular thoughts and emotions that one may be feeling now is
connected to past life events. It is likely that the characteristics of the psychedelic experience
facilitate an awareness of one’s thoughts, beliefs, emotions, and behaviors that were either
previously unknown or may have been pushed aside as to not self-reflect. When one’s thoughts
and emotions can be separated from the sense of self, individuals can begin to alter their
perspectives of why certain challenging experiences are occurring in their life or why they may
feel that they are ‘stuck’ in situations.
Attributes of the mystical experience may enhance the sense of separation from the self
and perception of alternative perceptions of one’s thoughts and emotions, allowing individuals to
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immerse themselves in feelings such as universal connectedness, bliss, and love. Ego-dissolution
may allow individuals to understand that any concerns or problems they may have in their dayto-day life are relatively small and insignificant. All of these characteristics of the psychedelic
experience are likely to facilitate the perception of received insight. It would make sense then,
that insight would predict improved PF by modifying one’s life values and behavior, such as a
concern and understanding for the self and others (Lerner & Lyvers, 2006; Watts & Luoma,
2020). Additionally, insight may facilitate greater awareness that alternative explanations exist
for why difficult situations occur and lead to various solutions. It should be noted that perceived
insight can potentially be extended for lengths of time with talk-therapy (Murphy-Beiner & Soar,
2020), however, there are gaps in the literature for how effective psychedelic-assisted
psychotherapy is for improving insight long-term and the extended relationship between insight
and PF.
The Current Study
Given gaps in the literature, the current study’s goal is to determine associations between
psychological flexibility and characteristics of the psychedelic experience including perceived
meaningful intention, feelings of comfort/safety prior to and during the psychedelic experience,
mystical experiences, ego-dissolution, and insight. The following hypotheses are proposed:
1. Perceived meaningful intention and feelings of comfort/safety during the psychedelic
experience are expected to be associated with psychological flexibility, decentering,
mystical experiences, ego-dissolution, and insight (see figure 2a).
2. Decentering, mystical experiences, ego-dissolution, and insight are expected to be
associated with greater psychological flexibility (see figure 2b).
Methods
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Participants
The current study recruited participants from social media (e.g., Reddit, Facebook) who had
previously used classic psychedelics or were interested in using classic psychedelics within the
next year. Inclusion criteria included being 18 years of age or older at the time of taking the
survey and having a working proficiency of English. As of July 12, 2021, a total of 449
participants attempted the survey. For the purposes of the analysis reported here, only those who
had previously used a psychedelic are included. After cleaning the data, 22 participants were
removed, leaving a total of 427 eligible for analyses (Figure 1).
Of 164 participants who reported their age, the average was 31 years old (SD = 11.4;
ranging from 18-66) and 55.4% indicated having taken a classic psychedelic at least 10 times in
their life. Of 170 participants, the majority identified as male (61.2%), White/Caucasian
American/European American (74.3%), and heterosexual or straight (69.4%). Of 168
participants, 52.4% reported obtaining an education level below an Associate’s Degree and
47.6% reported an Associate’s Degree or greater. Most participants reside in North America
(79.4%) and earn an income before taxes of $74,999 or lower (63.5%). The detailed breakdown
of demographics appears in Table 1.
Procedure
The Institutional Review Board approved this study via exemption with limited review
(Protocol #: 2021-0011). Participants were recruited from social media postings on Twitter and
within psychedelic based groups on Facebook (e.g., ‘Ayahuasca Group’, ‘Psychedelics’,
‘Psychedelic Society’, ‘DMT’) and Reddit (e.g., ‘r/Acid’, ‘r/Ayahuasca’, ‘r/Psilocybin’,
‘r/Psychonaut’). A Qualtrics link to the survey was provided and interested participants could
click to a consent form entailing the study purpose and what qualifies as a classic psychedelic.
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For the purposes of this study, classic psychedelics were listed as LSD (D-Lysergic acid
diethylamide), Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine), Mescaline (3,4,5Trimethoxyamphetamine), DMT (N,N-Dimethyltryptamine), Ayahuasca, and 5-MeO-DMT (5Methoxy-N,N-dimethyltryptamine). Once the participant consented to participate, they were
directed to the survey, which first asked how many times they had taken a classic psychedelic.
Once the participant indicated the number of times they had taken a classic psychedelic
before, they were directed to further questions about their use (see ‘General Use Questions’ in
Appendix A for full list of questions). Participants who indicated never having used a
psychedelic before (i.e., psychedelic naïve) were prompted to respond to the following
assessments: Experiences Questionnaire, Mystical Experiences Questionnaire (Positive Mood
subscale), Cognitive Flexibility Inventory, and Religious Salience. If that participant had only
taken a classic psychedelic one time before, they were instructed to answer a set of questions
thinking about that experience. If the participant had taken a psychedelic more than once, they
were directed to answer the subsequent questions thinking of their most meaningful experience.
All participants who indicated at least one psychedelic experience then filled out the
following assessments: Experiences Questionnaire, Mystical Experiences Questionnaire
(Mystical, Positive Mood, and Space/Time subscales), Ego-Dissolution Inventory, Cognitive
Flexibility Inventory, Psychological Insight Questionnaire, and the Religious Salience Scale. All
participants were then prompted to answer demographic questions and concluded with a post
survey evaluation and resource page before being thanked and exited from the survey.
Materials
General Use Questions. The General Use section was implemented to gather context
surrounding their psychedelic experiences, and more specifically to respond to a series of
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characteristic questions regarding their most meaningful psychedelic experience if used more
than once and their only psychedelic experience if used once. The first question asked how many
times a participant had taken a classic psychedelic before. The questions consisted of the type of
psychedelic used, exact dose and believed strength of dose, route of administration, whether the
participant was under the influence of any other psychoactive substance(s) (excluding caffeine
and nicotine) and specification, and time since the experience. Next, the participant answered
questions regarding the context of the experience such as set and setting, intention and how
meaningful the participant appraised the intention to be, participant appraisal of emotions
directly prior to the experience, comfort/safety level directly prior to and during the experience,
and the presence of music. If music was present, participants were asked for how long it was
present, their preference towards the music, and if they felt the music guided them towards an
experience they would describe as beneficial or positive, neutral (no guiding effect), or
detrimental or negative.
Decentering. The decentering subscale of the Experiences Questionnaire (Fresco et al.,
2007) contains 13 items, which measure one’s ability to detach from the self and recognize
thoughts and emotions as temporary processes of the mind. Items were scored on a five-point
scale ranging from 1 (never) to 5 (all the time). Scores were summed to create a total, with
higher total and mean scores representing greater levels of decentering. Higher scores are also
representative of greater disidentification with content of negative thinking. Sample items
include “I can slow my thinking at times of stress,” “I can observe unpleasant feelings without
being drawn into them,” and “I am kind to myself when things go wrong”. Reliability of this
scale assessed by Cronbach’s α ranged from .83 - .94 in an undergraduate sample as well as a
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sample of adult ayahuasca users (McCracken et al., 2013; Soler et al., 2015). The current study
showed an α of .88.
Mystical Experiences. Three of four subscales from the Revised Mystical Experiences
Questionnaire (Barrett et al., 2015) contain a total of 27 items used to measure different types of
mystical experiences during a psychedelic session: mystical experiences, positive mood,
space/time. The fourth subscale, ineffability, was not included in this study as it only intends to
assess a difficulty of using words to communicate characteristics of experience. All items were
scored on a six-point scale ranging from 0 (None; not at all) to 5 (Extremely; more than ever
before in my life and stronger than four). Participants were instructed to think about their most
meaningful psychedelic experience (or most recent experience if they only used once before)
while responding to the items. Scores from the three subscales were summed to create a total,
with higher total and mean scores representing greater levels of the overall mystical experience.
With all three subscales combined, the current study showed an α of .96. To current knowledge,
no studies have assessed mystical experiences, positive mood, and space/time without
ineffability, therefore grouped reliability comparisons cannot be provided. More detail of the
three subscales can be found below.
Mystical Experiences Subscale. The Mystical Experiences Subscale contains 15 items
used to measure components of the mystical experience during a psychedelic session: internal
unity (i.e., a sense of oneness with the self, consciousness) external unity (i.e., a sense of oneness
with all things outside of the self), noetic quality (i.e., a sense that the experience serves as
objective truth), and sacredness (i.e., a sense of divine quality, worthy of reverence). Sample
items include: “Experience of oneness in relation to an ‘inner world’ within,” “Experience of
oneness or unity with objects and/or persons perceived in your surroundings,” “Gain of insightful
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knowledge experienced at an intuitive level,” and “Feeling that you experienced something
profoundly sacred and holy”. Previous studies showed high reliabilities (ranging from .93 - .96)
across psilocybin and 5-MeO-DMT experienced populations responding to online surveys and
laboratory experiments after receiving psilocybin (Davis et al., 2018; Schenberg et al., 2017;
Barrett et al., 2015; MacLean et al., 2012). The current study showed an α of .96.
Positive Mood Subscale. The Positive Mood Subscale contains six items used to measure
bliss, peace, and love during a psychedelic session. Sample items include: “Experience of
amazement,” “Experience of tenderness and gentleness,” and “Feelings of peace and tranquility”.
Previous studies showed acceptable to high reliability (α ranging from .71 - .92) across
psilocybin and 5-MeO-DMT experienced populations responding to online surveys and
laboratory experiments after receiving psilocybin (Davis et al., 2018; Schenberg et al., 2017;
Barrett et al., 2015; MacLean et al., 2012). The current study showed an α of .89.
Space/Time Subscale. This subscale contains six items used to measure an altered sense
of space/time. Sample items include: “Loss of your usual sense of time,” “Loss of usual
awareness of where you were,” and “Being in a realm with no space boundaries”. Previous
studies showed high reliability (alphas ranging from .81 - .93) across psilocybin and 5-MeODMT experienced populations responding to online surveys and laboratory experiments after
receiving psilocybin (Davis et al., 2018; Schenberg et al., 2017; Barrett et al., 2015; MacLean et
al., 2012). The current study showed an α of .88.
Ego-Dissolution. The ego-dissolution subscale of the Ego-Dissolution Inventory (Nour et
al., 2016) consists of eight items used to measure the loss of a sense of self, the extent by which
ego-boundaries are disrupted during the psychedelic session, and an increased sense of union
with surroundings. Participants responded to each item thinking of their most meaningful
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psychedelic experience. Items were scored from 0 (“No, not more than usually”) - 100 (“Yes,
entirely or completely”) in increments of one. Scores were summed to create a total, with higher
total and mean scores representing greater levels of ego-dissolution. Sample items include: “I felt
at one with the universe,” “I felt a sense of union with others,” and “I felt far less absorbed by
my own issues and concerns''. Previous studies showed reliabilities (α from .81 - .93) across
online survey samples of psychedelic, cocaine, and alcohol users (van Mulukom et al., 2020;
Nour et al., 2016). The current study showed an α of .88.
Psychological Flexibility. The Cognitive Flexibility Inventory (Dennis & Vander Wal,
2010) consists of 20 items used to measure three aspects of cognitive flexibility. These include
the tendency to perceive difficult situations as controllable, the ability to perceive multiple
alternative explanations for life occurrences and human behavior, and the ability to generate
multiple alternative solutions to difficult situations. Items were measured on a scale of 1
(Strongly disagree) to 7 (Strongly agree) with six items being reverse scored. Items were then
summed to create a total. Sample items include: “I consider multiple options before making a
decision,” “When encountering difficult situations, I become so stressed that I cannot think of a
way to resolve the situation (R),” and “I often look at a situation from different viewpoints”.
Previous studies showed reliabilities (α from .86 - .91) across university undergraduates and a
sample of adult clinical outpatients (Kurginyan & Osavolyuk, 2018; Shareh et al., 2014; Dennis
& Vander Wal, 2010). The current study showed an α of .91. It should be noted that the
Acceptance and Action Questionnaire II is generally used for assessing PF in psychedelic users
(Close et al., 2020; Davis et al., 2020), however, it was not chosen for this study as confirmatory
factor analyses shows it reflects psychological distress (e.g., “My painful experiences and
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memories make it difficult for me to live a life that I would value”) more so than PF (Gámez et
al., 2011; Tyndall et al., 2019).
Insight. The Psychological Insight Questionnaire (Davis et al., 2020) consists of 28 items
used to measure the degree to which respondents experience acute insight that sometimes occurs
as a result of psychedelic use. Items are scored from zero (“No; not at all”) to five (“Extremely,
more than ever before in my life”) and were then summed to create a total. Participants
responded to items thinking of their most meaningful psychedelic experience or most recent if
they have only experienced once. Sample items included: “Realized how current feelings or
perceptions are related to events from my past,” “Discovered how aspects of my life are affecting
my well-being,” and “Discovered a clear pattern of avoidance in my life”. Previous studies
showed high reliability (α of .93) across samples of classic psychedelic and non-classic
psychedelic (e.g., Iboga/Ibogaine, Salvia/Salvinorin) experienced survey respondents (Davis et
al., 2021, 2020). The reliability in the current study was also quite high (α of .97).
Religious Salience. The Religious Salience Scale (Blaine & Crocker, 1995) is a fiveitem assessment that measures the prominence or importance of religion in everyday thought and
feelings. Items were measured on a scale from 1 (“Strongly Disagree”) to 7 (“Strongly Agree”).
Participants were instructed that where the word ‘God’ is used, to feel free to substitute a word
that captures what it means to the participant (e.g., Great Spirit, Nature, a Positive Energy, a
Divine Being, etc.). Sample items include: “My religious or spiritual beliefs are what lie behind
my whole approach to life,” “I am frequently aware of God in a personal way,” and “Being a
religious or spiritual person is important to me”. All items were then summed to create a total
score for each participant. Previous studies showed reliabilities ranging from an α of .94 - .97
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across adult and undergraduate samples (Exline et al., 2014; Wood et al., 2010). The current
study showed a high reliability of .94.
Demographics. Participants were prompted to respond to questions regarding age,
gender identity, sexual orientation, education level, income, residence, race/ethnicity, religious
affiliation (e.g., Catholic, Jewish, Buddhist, Muslim, Taoist), and religious identification (e.g.,
Spiritual, Agnostic, Atheistic) in order to adequately describe the sample of participants who
agreed to be in the study.
Planned Data Analysis
All analyses were performed within IBM SPSS Statistics – Version 27, using pairwise
deletions in order to maintain an adequate sample size with cases that would have otherwise been
filtered out due to missing data on certain variables. All continuous study measures (e.g.,
Psychological Flexibility, Insight) were shown to be normally distributed with a skewness within
-1 to 1 and a kurtosis within -3 to 3 (Kim, 2013). See Table 2 for a full breakdown of skewness
and kurtosis. SPSS revealed one extreme outlier and a decision not to remove it was chosen as
the outlier appeared on only one measure, psychological flexibility. Analyses were first run for
descriptives such as demographics and psychedelic use characteristics. Following descriptives,
hypotheses analyses were run.
Pearson correlations were used to assess strength and direction between demographics,
psychedelic consumption characteristics, and study variables. Independent Samples T-Tests were
then used for dichotomous variables (e.g., Under the influence of other substances, ‘If no current
religious affiliation, were you previously affiliated’) and One-Way ANOVAs were run for multicategorical variables (e.g., ‘Education Level’, ‘Number of classic psychedelic experiences’). For
T-Tests, equal variances were assumed if ⍺ > .05 and not assumed if ⍺ ≤ .05. For ANOVAs,
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Levene’s Test for Equality of Variances was used to assess homogeneity of variance. To meet
the assumption of homogeneity of variance, p > .05 was needed. P ≤ .05 indicated a violation of
this assumption. It was decided that variables which met homogeneity of variance would be
further analyzed using the Scheffe post-hoc, which is appropriate for use with studies of unequal
sample size (Nawi et a., 2020). Variables that violated homogeneity of variance were unable to
proceed with a One-Way ANOVA, and in those cases it was recommended that the Welch test
be used along with Games-Howell post hoc (Lee & Lee, 2018; Vogt & Johnson, 2011).
All main study hypotheses were examined using multiple linear hierarchical regression
analyses, in which all assumptions were met (i.e., no multicollinearity, values of residuals are
independent, variance of residuals are constant, values of residuals are normally distributed, no
influential cases biasing model using Cook’s Distance). A-priori power analyses were conducted
using the online Soper calculator (Soper, 2022) in order to determine the minimum sample size
for regression analyses. All a-priori sample size calculations were conducted using a medium
effect size (f2) of .15, given existing literature (Cohen, 1988), power of 0.8, and p = .05.
Calculations suggested a minimum sample size of 67 to analyze associations between
perceived meaningful intention and feelings of comfort/safety during the psychedelic experience
with decentering, mystical experiences, ego-dissolution, and insight (H1). A minimum sample
size of 84 was suggested to analyze associations between psychological flexibility with
decentering, mystical experiences, ego-dissolution, and insight (H2). Any descriptive variable
having a significant association with dependent variables were planned to be added as covariates
in the regression models, thereby increasing the required sample size to detect reliable effects. To
reduce type one error, p ≤ .01 was used for H1. After accounting for missing data using pairwise
deletions, an adequate sample size was met for 3 of the 5 regressions tested (for mystical
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experiences, decentering, and insight). For two of the five regressions, the minimum suggested
sample sizes of 141 for psychological flexibility and 134 for ego-dissolution were not met.
However, the minimum sample size was met for p ≤ .05 (N = 124 and N = 131, respectively). All
other regression analyses conducted for this study met the minimum required sample size
(Anderson, 2020). It is important to note that these are estimated effect sizes and may not reflect
actual sample size needed. Additionally, ordinary least square (OLS) regressions have been
shown in Monte Carlo studies to be robust and reliable in samples as small as 20 participants
(Gavilanes, 2020).
Results
The results are organized in two sections: descriptives and hypothesis testing. Within the
descriptive section, psychedelic consumption characteristics, such as the number of classic
experiences a participant reported to have in their life and the substance used for the experience
they reported on, are included for a better understanding of the sample when interpreting results.
Descriptives also contain the assessments of central tendency for each measure used, as well as
associations between demographics and study variables. The second section presents results from
three hypotheses conducted using hierarchical multivariate linear regression analysis.
Descriptive Statistics
Psychedelic Consumption Characteristics
The majority of participants reported taking a classic psychedelic at least 10 times in their
life (55.4%). The two most common psychedelics indicated were LSD (44.4%) and psilocybin
(39.1%). Of the current sample, most participants characterized their dose as moderate (36.9%)
or moderately high (37.3%) and consumed the substance orally (81.7%). Data indicated that the
majority (63.1%) of the sample were not under the influence of other substances (excluding
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caffeine and nicotine) during the psychedelic session that they held in mind while responding to
the survey; the session they reported on happened within one year of survey completion (64.9%).
Music was present for 86.8% of the sample with the majority (65.3%) reporting a beneficial or
positive effect of music during the session. A detailed breakdown of consumption characteristics
appears in Table 3.
Study Variable Descriptives
Measures of central tendency were used to understand how participants rated various
components of their psychedelic session, from the depth of their mystical experiences to
acquiring insight from the experience. All means, standard deviations, and ranges appear with
the normality variables in Table 2. For psychological flexibility (i.e., Cognitive Flexibility
Inventory), participants reported a mean score of 110.90 (SD = 15.41) out of the possible score
of 138. Overall, this would indicate that the majority of respondents “Agreed Somewhat” to each
item on a scale from 1 to 7 (Item Mean = 5.55; SD = .77). No psychedelic research studies to
current knowledge have assessed PF using the Cognitive Flexibility Inventory, however a study
by Khodarahimi et al. (2020) investigated flexibility using the CFI on opioid substance abuse
patients receiving Quality of Life Therapy and on a control group not receiving therapy. Findings
revealed a pre-test mean of 94.72 (SD = 9.04) and post-test mean of 103.05 (SD = 6.81). The
pre-test control group mean was 94.72 (SD = 9.04) and post-test was 95.93 (SD = 7.24). Of note,
quality of life therapy involves principles such as making happiness a habit, learning to forgive,
and being optimistic. These principles are similar to characteristics that may arise during a
psychedelic experience and stay with users following the session(s) such as acceptance, feelings
of bliss, and connectedness (Barrett et al., 2015; Carhart-Harris et al., 2016), suggesting a

Psychedelic Use and Psychological Flexibility

40

positive impact for individuals who are mindful of these principles as seen through similar means
following Quality of Life therapy and as reported by participants in the current study.
Participant responses on decentering, or the Experiences Questionnaire, (M = 45.14; SD
= 8.92) showed relatively similar scores compared to other studies with a maximum possible
score of 63. This finding corresponds to an item mean of 3.47 (SD = .69), indicating that most
participants reported decentering “About half the time” on a scale from 1 to 5. Murphy-Beiner
& Soar (2020) investigated decentering in ayahuasca users baseline and 24 hours following use.
Baseline showed a mean score of 40.60 (SD = 5.48) compared with a mean of 41.75 (SD = 7.29)
24 hours following use; differences pre-post were found to be significant. Franquesa et al. (2018)
also explored decentering following ayahuasca use, however included individuals who have
never used (M = 40.29; SD = 5.73), those who have used 1-15 times (M = 40.88; SD = 6.20),
and those who have used more than 15 times (M = 45.08; SD = 5.71). All three groups were
significantly different. The closeness of the current study’s mean with participants who have
used ayahuasca more than 15 times is appropriate given that the majority of participants for the
current study reported using psychedelics 10+ times. This high score of decentering suggests that
most participants appraised themselves as having the ability to separate from the self, and view
their thoughts and emotions as temporary, instead of ruminating over them.
Three of the four subscales of the Mystical Experiences Questionnaire were used to
measure components of the psychedelic experience: internal unity, external unity, noetic quality,
sacredness. These include the ‘mystical’ subscale as well as positive mood, and an altered sense
of space/time. The current study revealed a total score mean of 97.48 (SD = 29.77) out of a
possible 135, suggesting that most participants generally agreed to experiencing various features
of a psychedelic session such as a deep sense of connection within and outside of the self,
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feelings of bliss and/or love, a sense of reverence towards the experience, feeling that what was
experienced is a truth, and being outside of space/time. The finding corresponds to an item mean
of 3.61 (SD = 1.10) on a scale from 0 to 5. This mean is greater than mystical experiences
reported by participants of other studies following the use of 5-MeO-DMT (Item Mean = 2.82;
SD = .11; Barsuglia et al., 2018); it is also greater than those who have taken moderate (Item
Mean = 2.31; SD = .18) to high (Item Mean = 2.58; SD = .18) doses of psilocybin (Griffiths et
al., 2011).
Ego-dissolution was assessed using the Ego-Dissolution Inventory in which data revealed
a mean score of 531.82 (SD = 190.02) of a possible 800. The item mean for ego-dissolution was
66.48 (SD = 23.75) on a scale from 0 to 100, which suggests that while under the influence of
psychedelics, participants generally agreed to experiencing a loss of the sense of self (i.e.,
identity), disrupted ego-boundaries, and greater external connection. Participants within the
current study reported greater averages of ego-dissolution than data presented by other studies.
Uthaug et al. (2018) assessed participants on ego-dissolution the day following an ayahuasca
experience as well as four weeks later with data indicating a mean of 480 (SD = 218.4).
The Psychological Insight Questionnaire was used to assess participants’ sense of
received insight as a result of the psychedelic session. The reported mean was 89.02 (SD =
35.76) out of a possible 140, which translates to an item mean of 3.18 (SD = 1.28) on a scale
from 0 to 5. A previous cross-sectional study exploring insight in psilocybin and LSD users
revealed a mean of 86.9 (SD = 45.9; Davis et al., 2021), similar to that of the current study,
which makes sense given that the majority of participants reported using LSD or psilocybin. This
mean score of insight suggests that as a result of the psychedelic session, most participants were
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able to realize aspects of their life they had been previously unaware of such as life goals or life
purpose and clarity of circumstances or events a participant felt had been holding them back.
Associations between Demographics and Study Variables
Correlations appear in Table 4. Age was found to be significantly associated with PF, r
(154) = .16, p = .05 and intention r (148) = .21, p = .01. Socioeconomic variables of income and
education were each only significantly associated with one study variable: education negatively
with insight, r (156) = -.17, p = .04 and income positively with PF, r (133) = .32, p < .001.
The number of psychedelic experiences participants reported was significantly associated
with decentering r (247) = .29, p < .001, mystical experiences r (224) = .35, p < .001, egodissolution r (182) = .27, p < .001, insight r (174) = .37, p < .001, and psychological flexibility r
(197) = .31, p < .001. These associations suggest that the number of classic psychedelic
experiences users have might serve a role in increasing the strength of each of these study
variables.
Dose characterization was revealed to have a significant negative association with
comfort/safety during the experience r (253) = -.15, p = .02, indicating that as dose increases, the
experience may become more intense, and could cause individuals to feel less comfortable or
safe. Dose characterization was also significantly associated with decentering r (247) = .19, p
=.002, mystical experiences r (222) = .35, p < .001, ego-dissolution r (182) = .34, p < .001, and
insight r (174) = .17, p = .03.
Significant associations were found for religious salience and intention r (147) = .33, p <
.001, decentering r (162) = .30, p < .001, mystical experiences r (159) = .33, p < .001, egodissolution r (132) = .23, p = .009, insight r (154) = .34, p < .001, and psychological flexibility r
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(154) = .27, p < .001. These results suggest a positive relationship between the importance of
religion or spirituality in a participant’s everyday life and the study variables.
Independent Samples T-Tests and One-Way ANOVAs
Independent Samples T-Tests and One-Way ANOVAs were conducted to determine any
significant differences on study variables by categorical demographics and use variables. It is
important to note that although some variables can technically be measured as categorical, they
could also be run as continuous (e.g., education, income, number of classic psychedelic
experiences). Independent samples t-tests did not reveal any significant differences for being
under the influence of other substances compared to not being under the influence, nor were
there differences by sexual orientation.
A one-way ANOVA found significant differences between the type of psychedelic used
and intention F (3, 215) = 5.52, p = .001. Scheffe revealed LSD to be significantly different from
psilocybin at p = .044 and ayahuasca at p = .006 such that those who used ayahuasca reported the
greatest self-perceived meaningful intention followed by psilocybin and then LSD. Significant
differences were also found for substance type and mystical experiences F (3, 56.38) = 11.97, p
< .001. Games-Howell revealed LSD to be significantly different from DMT at p < .001 and
ayahuasca at p < .001 such that those who used DMT reported the greatest mystical experiences
followed by ayahuasca and then LSD. Psilocybin was significantly different from DMT at p <
.001 and ayahuasca at p = .005. Participants reported greater ratings of perceived meaningful
intentions with the use of ayahuasca compared to the other substances as well as greater mystical
experiences with DMT followed by ayahuasca.
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A significant difference was also revealed for participant residence on intention F (2,
145) = 7.81, p < .001. Scheffe revealed a greater mean for North America compared to Australia
at p = .004. No other study variables were significantly different across demographics.
Tests of Hypotheses
The Role of Intention and Comfort/Safety on Psychological Flexibility and its Proposed
Predictors
H1 predicted that there would be a significant association between intention and
comfort/safety during the experience and five outcome variables: psychological flexibility,
decentering, mystical experiences, ego-dissolution, insight. To examine these associations, five
hierarchical regressions were conducted. Each regression included demographics and
psychedelic use variables that were significantly associated with the dependent variables as
covariates to control for their influence on the DV. In this way, the unique association with the
hypothesized predictors and the DV could be established over and above demographic and use
variables.
Regression one was conducted with psychological flexibility as the outcome variable. See
Table 5. PF was associated with age, income, religious salience, number of classic experiences,
and comfort/safety going into the experience, therefore these variables were used as covariates to
control for potential influences on PF. Age and income were introduced in model one F (2, 122)
= 7.048, p = .001, R2 = .09, religious salience in model two F (3, 121) = 8.973, p < .001, R2 =
.16, number of psychedelic experiences and comfort/safety going into the experience in model
three F (5, 119) = 8.267, p < .001, R2 = .23, comfort/safety during the experience into model four
F (6, 118) = 7.353, p < .001, R2 = .24, and intention into the final model F (7, 117) = 7.877, p <
.001, R2 = .28. In the final model, demographics that retained significance included the number
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of classic experiences participants reported and was positively associated with psychological
flexibility β = .21, t(124) = 2.68, p = .009 along with religious salience β = .20, t(124) = 2.43, p =
.017 and income β = .36, t(124) = 4.11, p < .001. Intention was the only hypothesized variable to
remain associated with psychological flexibility in the final model β = .24, t(124) = 2.88, p =
.005 once other variables were controlled for. Given that covariates were included in the
regression, re-running the power analysis with seven predictors would require an N of 103 for .8
power with alpha at .05, however if a more stringent alpha is used (.01), the required N would be
141. The sample size for the current regression provided enough power for an alpha of .05.
Regression two was conducted on decentering as the outcome variable. Decentering was
associated with the number of classic experiences participants reported, religious salience, and
comfort/safety going into the experience, therefore these variables were used as covariates to
control for potential influence on decentering (See Table 6). Religious salience was introduced
into model one F (1, 145) = 13.812, p < .001, R2 = .08, the number of classic experiences and
comfort/safety going into the experience within model two F (3, 143) = 8.993, p < .001, R2 = .14,
comfort/safety during the experience into model three F (4, 142) = 8.591, p < .001, R2 = .17, and
intention into the final model F (5, 141) = 7.841, p < .001, R2 = .19. See Table 6. The final model
revealed significant associations with religious salience β = .22, t(146) = 2.74, p = .007 and the
number of classic experiences reported β = .23, t(146) = 3.02, p = .003. Both hypothesized
variables, comfort/safety during the experience β = .19, t(146) = 2.50, p = .013 and intention β =
.16, t(146) = 2.02, p = .045, were significantly associated with decentering, over and above the
covariates. The current regression’s sample size allowed for adequate power at the .01 level of
significance.
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Regression three was conducted on mystical experiences as the outcome variable (Table
7). Mystical experiences was associated with the number of classic experiences participants
reported, substance type, dose characterization, religious salience, and comfort/safety going into
the experience, therefore these variables were used as covariates to control for any influence over
mystical experiences. Because substance type was a categorical variable, it was dummy coded
using the ‘k-1’ method with psilocybin as the reference category (Alkharusi, 2012). Religious
salience was introduced in model one F (1, 145) = 18.102, p < .001, R2 = .11, number of classic
experiences, comfort/safety going into the experience, dose characterization, and substance type
into model two F (7, 139) = 8.259, p < .001, R2 = .26, comfort/safety during the experience into
model three F (8, 138) = 8.083, p < .001, R2 = .28, and intention into model four F (9, 137) =
7.416, p < .001, R2 = .28. See table 7. Final model results showed significant associations with
religious salience β = .23, t(146) = 2.90, p = .004, the number of classic experiences participants
reported β = .17, t(146) = 2.16, p = .032, and dose characterization β = .26, t(146) = 3.34, p =
.001. Comfort/safety during the experience was the only hypothesized variable significantly
associated β = .17, t(146) = 2.24, p = .027 once demographics and use characteristics were
controlled for. Adequate power was met for significance at the .01 level.
Regression four was conducted on ego-dissolution as the outcome variable. Egodissolution was associated with the number of classic experiences participants reported, dose
characterization, religious salience, and comfort/safety going into the experience, therefore these
variables were used as covariates to control for potential influence. Religious salience was added
into model one F (1, 130) = 6.968, p = .009, R2 = .04, number of classic experiences, dose
characterization, and comfort/safety into model two F (4, 127) = 7.233, p < .001, R2 = .16,
comfort/safety during the experience into model three F (5, 126) = 6.315, p < .001, R2 = .17, and
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intention into model four F (6, 125) = 5.321, p < .001, R2 = .17. See Table 8. Model four
indicated that there were significant associations with religious salience β = .21, t(131) = 2.49, p
= .014 and dose characterization β = .30, t(131) = 3.34, p = .001. Given that covariates were
included in the regression, re-running the power analysis with six predictors would require an N
of 97 for .8 power with alpha at .05, however an alpha of .01 would require an N of 134. The
sample size for the current regression provided enough power for an alpha of .05 with 131
participants.
Regression five was conducted on insight as the outcome variable. Insight was associated
with education level, number of classic experiences, dose characterization, and comfort/safety
going into the experience, therefore these variables were used as covariates to control for
potential influence on over insight. Education level was added into model one F (1, 148) = 4.336,
p = .039, R2 = .02, dose characterization, number of classic experiences, and comfort/safety into
model two F (4, 145) = 7.001, p < .001, R2 = .14, comfort/safety during the experience into
model three F (5, 144) = 5.567, p < .001, R2 = .13, and intention into the final model F (6, 143) =
7.38, p < .001, R2 = .20. See Table 9. The final model showed an inverse significant association
with education level β = -.19, t(149) = -2.53, p = .013. The number of classic experiences was
also significantly associated β = .34, t(149) = 4.17, p < .001 along with intention β = .28, t(149) =
3.73, p < .001. The current regression sample met adequate power for a significance of .01.
Predicting Psychological Flexibility
H2 predicted an association between decentering, mystical experiences, ego-dissolution,
insight and psychological flexibility itself. To examine these hypothesized associations, one
hierarchical regression was conducted with psychological flexibility as the outcome variable. See
Table 10. Psychological flexibility was associated with age, income, religious salience, and
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number of psychedelic experiences, therefore these variables were entered first to control for
their influence on PF. Age and income were added into model one F (2, 112) = 6.471, p = .002,
R2 = .09, religious salience into model two F (3, 111) = 8.231, p < .001, R2 = .16, number of
classic experiences into model three F (4, 110) = 8.301, p < .001, R2 = .20, and decentering,
mystical experiences, ego-dissolution, and insight into model four F (8, 106) = 9.329, p < .001,
R2 = .37. Final model results found a significant association with income β = .26, t(114) = 2.95, p
= .004 and decentering β = .467, t(114) = 5.63, p < .001. Sample size was adequate for power at
the .05 level of significance.
Discussion
In the current study of classic psychedelic users, two hypotheses were investigated to
further understand associations between the perceived effects of classic psychedelics (psilocybin,
LSD, mescaline, ayahuasca, DMT, 5-MeO-DMT) and psychological flexibility. For hypothesis
one, participant’s feelings of comfort/safety during the experience and having a self-perceived
meaningful intention were expected to be associated with psychological flexibility and
characteristics of the psychedelic experience including decentering, mystical experiences, egodissolution, and insight.
After controlling for any potential influence that associated demographics and use
characteristics would have over the main study variables, results revealed interesting findings.
Upon investigation of the hypothesized variables, both intention and comfort/safety during the
experience were associated with decentering. Comfort/safety was also associated with mystical
experiences, whereas intention was additionally associated with PF and insight. It is important to
note that although the current study did not investigate causality, there may be a directional
relationship by which both intention and feelings of comfort/safety lead to the decentering.
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The process of decentering allows individuals to create a space between their sense of
self and any thoughts or emotions that arise during the psychedelic experience. During this
process, individuals who approach a session with therapeutic intent may be more likely to see a
basis for why they think or feel a particular way as well as have the opportunity to view these
thoughts, emotions, and experiences from another perspective. For example, prior to an
ayahuasca experience, one participant formed an intention about whether their romantic
relationship was right for them, and following the experience, felt that they received a greater
sense of autonomy and confidence (Bathje et al., 2021). In this case, it may be that decentering
allowed the individual to detach from their thoughts and emotions about the relationship, and
instead, alter their perspective to focus on how autonomous and confident they are. As a result of
this experience, this individual may have also received insight on how to proceed with the
relationship.
Forming an intention perceived as meaningful to the individual may be an important
preparation technique in understanding the reason(s) for having the experience in the first place,
and subsequent therapeutic outcomes (Pollan, 2018). Intention as a preparation technique is
useful in understanding the aims of the experience, hopes, and what an individual would like to
learn, and may influence what is likely to come as insight (Alpert et al., 1964). This
understanding can be useful in surrendering to, or accepting any challenging experiences that
arises during the session, through a deeper immersion (Wolff et al., 2020). In comparison, users
who have a less meaningful intention or who approach the session recreationally are more likely
to have challenging experiences (Aday et al., 2021). However, challenging experiences have
been shown to be associated with increased well-being while looking back on the experience
(Barrett et al., 2017; Carbonaro et al., 2016).
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Furthermore, hypothesis one revealed perceived meaningful intention to be associated
with PF and insight, suggesting that approaching a psychedelic session with self-perceived
meaningful intention, such as accepting challenging experiences encountered in the past or
personal growth in the direction an individual should take their life, could be one way by which
users may have experiences or thoughts that move them in the direction towards perceived
insight. It is likely that this insight is facilitated by the separation of one’s sense of self and their
thoughts and emotions, therefore providing the user novel insight that was previously unknown
or intentionally ‘bottled-up’ to not have to face the challenge. Following the psychedelic
experience, insight might assist in increasing PF, therefore allowing individuals to adapt to new
situations, some of which could be challenging. Additionally, these individuals may have a
greater ability to not only be aware of day-to-day life events, but also perceive multiple
explanations for why they might occur and come up with various solutions.
In addition to findings related to perceived meaningful intention, regression analyses
showed associations between feelings of comfort and safety during the experience and
decentering, as well as mystical experiences. It may be that when individuals feel more secure in
their set and setting, they can allow their mind to wander and detach easier. This can be
compared to feelings of insecurity and possibly being in a situation where a user did not feel they
were able to let their mind wander or detach, perhaps wanting to stay aware of their
surroundings. A dismissal of context could possibly lead to psychedelic use not only being
clinically ineffective, but also harm-inducing to the user (Albarelli, 2009; Carhart-Harris et al.,
2018; Ludwig et al., 1969). Greater feelings of security during the experience may also allow
mystical experiences to flow with ease and less resistance. Aside from being in a secure
environment, resistance to surrendering, or the inability to ‘let go’ during psychedelic
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experiences may also lead to feelings of diminished security. It is likely that individuals who
have more experiences with psychedelic states of consciousness may resist less, or perhaps feel
more comfort/safety, as familiarity becomes apparent and the user realizes these feelings of
space/time loss or God/cosmic entities are not new, but are yet another form the mystical-type
experience can take. More experience might also allow a user to maneuver and understand the
experiences and the message being conveyed with more ease.
Interestingly, neither mystical experiences nor ego-dissolution were found to be
associated with intention. This contrasts other studies which have shown that spiritual
motivations and clear intentions lead to mystical experiences and ego-dissolution (Haijen et al.,
2018; Russ et al., 2019). One underlying reason might be that the majority of participants in this
study reported using psychedelics six months or longer from the time they responded to the
survey items. It may be that as time passed, the participants in the current study either
underscored or overscored certain items such as underscoring the meaningfulness of their
intention, which might have resulted in no significant associations between mystical experiences,
ego-dissolution, and intention.
Additionally, ego-dissolution, insight, and PF were not associated with feelings of
comfort and safety during the experience. It could be that feelings of comfort/safety during the
experience may not be as important for insight or PF, and instead, may be more important for
decentering and mystical experiences, where individuals detach from their thoughts and
emotions, viewing them from alternative perspectives, which can be scary. For example, when
an individual feels safe or comfortable in their setting, it is more likely that they will be able to
decenter and have mystical experiences that perhaps reflect or deepen the process of decentering.
An individual who is not comfortable or safe will have a more difficult time detaching and may
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resist the mystical experiences. Decentering or mystical experiences may also serve as mediators
between comfort/safety and insight or PF, which could explain the non-significant direct
associations with these two variables. Although mystical experiences were associated with
feelings of comfort/safety in the bivariate correlations, when one’s sense of self is significantly
or completely ‘dissolved’ (i.e., ego-dissolution), sensations of comfort and safety may also cease
to exist, and may be why ego-dissolution and comfort/safety during the experience were not
correlated.
As a result of controlling for potential influences on the hypothesized variables,
interesting patterns emerged with demographics and use characteristics. One notable
demographic was religious salience, which was associated with all of the study variables:
decentering, mystical experiences, ego-dissolution, insight, and PF. These results not only
suggest that the psychedelic experience may have a spiritual nature to it, but that participants
who score high on religious salience may also facilitate improvements to PF. In a study by
Griffiths et al. (2008), psychedelic naive participants who indicated regular participation in
religious or spiritual activities were given high doses of psilocybin and results showed that at a
14-month follow-up, 67% reported the experience to be among the top five most spiritually
significant and personally meaningful experiences in their life. More than half of these
participants met criteria for a complete mystical experience. A more recent study showed that
more than two-thirds of participants (not reported whether participants were previously
psychedelic naive or not) who indicated a God-encounter experience via non-drug and
psychedelic use no longer identified as atheist following the experience. Approximately half of
the participants met a priori criteria for complete mystical experience (R. R. Griffiths et al.,
2019). These results extend the notion that a spiritual quality can exist within the psychedelic
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experience, and that individuals who score high on religious salience can facilitate increases to
decentering, mystical experiences, ego-dissolution, and PF, thus allowing greater adaptation
within everyday life events and potentially challenging experiences. It should also be noted that
the majority of participants reported 10+ experiences, likely indicating that they generally lean
towards an objective truth and sacredness of the experience. This may be because individuals
who use, already score high in religious salience or it may be that using often facilitates deeper
connections with characteristics of the psychedelic experience and thus, PF.
Alternatively, it may be that participants who score high on religious salience are more
likely to describe their experiences the same way that the scales do. This could be due to artifact
in assessment by which the measured items cued certain responses from the participant,
particularly from participants who score high versus low on religious salience. The wording of
the scale items might be more geared towards individuals who have a particular vocabulary or
tendency to use certain words. In either case, religious salience has not been explicitly studied in
this line of research and suggests a promising area of future investigation.
Another finding that emerged amongst the control variables was for previous psychedelic
experience, which was associated with decentering, mystical experiences, insight, and PF (but
not with ego-dissolution). Additionally, dose characterization was associated with both mystical
experience and ego-dissolution. It makes sense that with previous psychedelic experience,
participants would be familiar with the ‘flow’ of the session. This increased understanding may
lessen the likelihood of resistance among decentering and mystical experiences as well as
increase likelihood of surrendering, thus the individual is able to perceive greater insight and PF.
Additionally, an understanding of how the experience flows could also make it more likely that
the individual would make sure they are in a context (i.e., set and setting) that they feel
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comfortable in and are ready for the session, extending enhancements to characteristics of the
experience and PF.
For dose characterization, it makes sense that a larger dose of a psychedelic would likely
be needed to have mystical experiences and ego-dissolution. However, a larger dose would not
necessarily be required for decentering, insight, or PF. How each individual perceives and
handles the psychedelic experience is very different. As an example, some individuals who take
a larger dose may not be as prepared for the experience as they may have believed, and it could
also be that the intense nature of a larger dose might bring fear or anxiety to the user, not
allowing for an adequate process of decentering, perception of insight, or PF. Additionally, this
could also be explained by the previously mentioned potential mediation model involving
feelings of comfort/safety, which suggests more complex statistical analyses would be warranted
in future investigations.
Finally, results found a significant association between income and PF as well as an
inverse association between education level and insight. To current knowledge, no studies have
explored a relationship between income and PF, and only one study used income as a control
variable with no association linked with PF (Johansen & Krebs, 2015). However, it may be that
PF and income have some influence over each other. A greater income might lead to greater PF
as these individuals are able to pay for more psychedelic experiences, whether that is at home or
in an international ayahuasca retreat with medical professionals available to help and amenities
to ensure comfort/safety. And more generally, greater income could provide an individual with
other experiences and opportunities that can build PF (e.g., therapy, meditation classes). Given
the cross-sectional design of this study, it might also be that given PF entails greater flexibility
and adaptability in multiple areas of one’s life, individuals with greater PF could pursue work or
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take opportunities that provide greater income. Additionally, individuals with greater PF may be
more likely to solve problems with alternative solutions compared to individuals with low PF,
which might lead to greater income. Similarly, individuals with low PF may not adapt as well to
change in life circumstances or come up with solutions to problems faced at their work, perhaps
leading to lower paying jobs or even to losing income. Longitudinal designs are needed to further
investigate this association.
In terms of the inverse association found between education and insight, it may be that as
individuals receive more academic education, they are more likely to question the perceived
insight that the psychedelic experience brings about following the session. Questioning thoughts
and emotions might also occur during the experience, which in turn may lead to resistance and
reduced perceived insight. As an example, an individual might ask themselves if the mysticaltype experience and perceived insight is how they genuinely feel or is just a by-product of the
substance and its psychological effects.
Hypothesis two proposed that decentering, mystical experiences, ego-dissolution, and
insight would be associated with PF. After controlling for potential influences that demographics
and use characteristics would have over the main study variables, results revealed that
decentering was the only hypothesized variable significantly associated with PF. Interestingly,
mystical experiences, ego-dissolution, and insight were not associated with PF; however, this is
contrary to the bivariate correlations which showed these three variables to be positively
correlated with PF. These findings could speak to the need to examine these characteristics
altogether instead of separately. It is likely that these characteristics of the psychedelic
experience (e.g., decentering, mystical experiences, ego-dissolution, and insight) work together
in their association with PF, instead of separate associations. Alternatively, it might be that
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adding decentering to the model made it so that the other characteristics became insignificant.
Decentering may have the greatest association with PF because it would allow detachment from
thoughts and emotions, viewing them from other perspectives. Taking these findings into
account, the current regression analysis suggests that there may be a more complex relationship
in associations with PF, which may only have been partly explained by mystical experiences,
ego-dissolution, and insight.
Theoretically, it may be the case that there is a spiral or feedback loop model in place that
makes it difficult for these characteristics of the psychedelic experience to be parsed out. Some
of these characteristics might also be occurring simultaneously. Perhaps following feelings of
comfort/safety during the experience and self-perceived meaningful intention, it could be that
decentering, or detaching one’s sense of self from their thoughts and emotions in order to view
alternative perspectives, could lead to mystical experiences, ego-dissolution, and insight,
followed by increases in PF. A feedback loop might also be occurring here in multiple ways. For
example, decentering may lead to mystical experiences, and in turn, these mystical experiences,
which can involve visualizing past and current life experiences, can lead back to alternative
perspectives by which the user views past or current experiences. As another example, part of the
mystical experience and perhaps an extension in its depth, ego-dissolution can be a significant or
complete detachment from the sense of self and everything one is defined by, in which all that is
left is a deep feeling of universal connectedness. These feelings of connection and potential awe
experiences may lead back to alternative perspectives during decentering (e.g., an understanding
that any problem one has had or is currently facing is insignificant or easy to solve). It is most
likely that these characteristics of the psychedelic experience involve both feedback loops and
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simultaneous presence, in which each process is perceived to occur at the same time, and
therefore facilitates perceived insight.
Furthermore, it would make sense that these characteristics of the psychedelic experience
do not occur only once during the session but might continue in loops for each thought and
emotion that arises, thus scores in PF would continue to improve as insight is perceived.
Improvements in PF would allow for the individual to adapt to various novel or challenging
experiences encountered in day-to-day life as well as perceive multiple explanations and
solutions for life events (Waldeck et al., 2021). This theoretical reasoning could potentially
explain why decentering was the only characteristic associated with PF. The linear hierarchical
regression conducted for H2 would not have accounted for feedback loops in addition to
simultaneous occurrence of these variables. In order to test these relationships, future research
would need to employ more advanced statistical tools.
Limitations
The current study has important limitations that should be noted. The greatest is that of
small sample size. For H1, all five hierarchical regressions were adequately powered at .05.
However, PF and ego-dissolution were underpowered at .01, which might be more appropriate to
use as a correction for the multiple analyses conducted. This lack of power for PF and egodissolution may have reduced the chances of finding a true effect. There were also some other
methodological limitations.
The current study is cross-sectional, therefore firm conclusions are not able to be drawn
regarding the direction of effects. However, it could be that both perceived meaningful intention
and feelings of comfort/safety lead to a greater likelihood of decentering occurring. Decentering
without resistance to one’s thoughts and emotions, in turn, may lead to mystical experiences, and
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as an extension of the mystical state, potentially ego-dissolution. Subsequently, increased
perceived insight and PF may follow, respectively. Additionally, a feedback loop could exist, by
which PF leads to more perceived insight, which then leads to greater PF and so forth, repeating
the loop. A study by Soler et al. (2015) revealed that 24 hours following an ayahuasca
experience, decentering is increased. This suggests that there may be a more complex
relationship in which decentering exists within the feedback loop, predicting greater perceived
insight following the psychedelic experience, thus longitudinal studies in larger samples is
needed to conduct the appropriate statistical analyses to test these possibilities.
Another methodological limitation is that participants were asked to answer all questions
regarding their most meaningful experience and were also permitted to choose that experience
regardless of the time that passed, which may have prompted greater responses involving their
most positive psychedelic experience. Challenging experiences have been shown to lead to
increased well-being in retrospect (Barrett et al., 2017; Carbonaro et al., 2016) and some
participants have also reported meaningful insights as a result of challenging experiences (Gashi
et al., 2021). Gaps still remain on whether PF may be reduced following a challenging
experience with psychedelics and then increase or return to baseline after a certain length of time
once the experience is processed.
In addition, if participants are very interested in psychedelic substances, there is also a
chance that they encountered information between the time they took the substance and the
survey, which could potentially bias their responses. Ottenstein & Lischetzke (2019) investigated
memory recall of emotions and showed that positive emotions were overestimated in retrospect,
whereas negative emotions were more accurate in recollection. Interestingly, individuals higher
in conscientiousness were found to have reduced recall bias for both positive and negative

Psychedelic Use and Psychological Flexibility

59

emotions. A remedy for this might be to recruit individuals who have had a psychedelic
experience within a certain period of time from the date of survey completion, such as one
month. Another solution could be the inclusion of assessments throughout various periods of
time following the session (e.g., directly after, 24 hours, two weeks, one month).
Another limitation revealed from the data is that 36.9% of 260 participants were under
the influence of another substance (e.g., cannabis, another psychedelic) while using the
psychedelic in mind for this study. The issue with being under the influence of other substances
is that it is difficult to pinpoint if associations made were due to the psychedelic experience the
participant had in mind, or whether certain variables such as decentering, mystical experiences,
and insight were increased or reduced due to participant use of cannabis, for example. Although
there was no significant differences between other substance use and no other substance use on
any of the study variables, future research may want to take this into account. It should also be
noted that another limitation is the lack of information about possible psychiatric disorders.
There was no exclusion criteria for any psychiatric disorder, so any influence this may have had
over the study variables is unknown.
Many gaps still remain on how psychedelics interact with other substances such as
cannabis or alcohol. A remedy to this issue would be to clearly state in the consent form that
only individuals who have used classic psychedelics by itself without any other psychoactive
substances (excluding coffee and tobacco) are eligible to participate. Alternatively, any
individuals who indicate multiple substance use could be excluded from analyses.
Strengths and Implications
Findings for the current study add to the emerging classic psychedelic literature on
psychological flexibility and the psychological processes which surround it. These implications
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not only apply to clinical use, but also to individuals who use psychedelics recreationally, or
outside of a medical environment for self-growth. Although causal conclusions were unable to be
drawn, the current study did focus on the associations of variables that may be important to
explore in future research studies.
Psychedelic research to date has mainly focused on how certain characteristics of the
psychedelic experience (e.g., intention, mystical experiences, insight) impact disorders such as
depression, anxiety, eating disorders, and addiction (Hosanagar et al., 2021; Johnson et al. 2017;
Muttoni et al., 2019). However, little research has been conducted on the potential associations
between multiple characteristics of the psychedelic experience. The current study aimed not only
to understand PF, but also how this construct interacts with perceived meaningful intention,
feelings of comfort and safety, decentering, mystical experiences, ego-dissolution, and perceived
insight.
Results indicated that there may be a deeper relationship between the study variables,
which previous studies have not accounted for. For example, the process of decentering may
serve a critical role in PF. By allowing participants to detach from their thoughts and emotions,
they can begin to perceive alternative explanations for why certain circumstances have occurred
in their life or even have a greater adaptability and understanding of their own thoughts and
emotions in viewing themselves, others, and the world. These individuals who are able to
decenter without resistance may be more likely to see improvements to well-being as shown
through some studies investigating outcomes of PF on chronic pain (Vowles & McCracken,
2010), cancer survivors (Hulbert-Williams & Storey, 2015), openness (Ramaci et al., 2019), and
post-traumatic stress symptoms (Boykin et al., 2020).
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Additionally, surrounding psychedelic use, this study is among the first to find that
feelings of comfort/safety during the experience and perceived meaningful intention are
associated with decentering. Future studies may want to continue exploring this association
through other methods such as structural equation analysis with a larger sample to investigate
whether feelings of comfort/safety and perceived meaningful intention lead to decentering, while
assessing the mediating pathways of characteristics such as mystical experiences and egodissolution. The investigation of decentering and how it is operationalized during the psychedelic
experience may be of importance for future researchers aiming to reveal patterns of causality,
direction, and outcomes. Both clinical studies and individuals who use psychedelics outside of a
medical setting would benefit from greater knowledge on how to set up a pleasing environment
to feel comfortable/safe as well as understand the importance of self-perceived meaningful
intention, which may ease the process of decentering during their experience. Future studies
might also want to assess whether the likelihood of decentering, having mystical experiences,
ego-dissolution, insight, and even PF varies by the type of psychedelic being used, even when
accounting for feelings of comfort/safety and perceived meaningful intention.
Interestingly, there are some variables that may be very important for future research to
explore, which have not been done thus far. These variables are religious salience and lifetime
psychedelic use, and have shown to be positively associated with numerous characteristics of the
psychedelic experience in the current study such as PF, decentering, and mystical experiences.
Further investigation of these variables might clarify whether psychedelics seem to improve
aspects of PF and well-being for some individuals better than others.
A methodological strength is that of inclusion criteria, namely that the study was not only
open to those within the US, but also internationally. Although the majority of participants were
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from the U.S., roughly 15% were located in Europe and 3% in Australia. This open inclusion
criteria allows for greater representation in addition to the inclusion of participants who may
have reported using substances that are generally more difficult to find, such as 5-MeO-DMT,
ayahuasca, or mescaline. Compared to LSD and psilocybin (reported to be the most used within
the current study), there is a larger gap in investigations of the other listed classic psychedelics.
The current study adds to the literature by listing all classic psychedelics for participants to
choose from and report on.
Additionally, the use of music during psychedelic sessions, whether the music occurs
within a ceremonial space or outside of one, may be important in outcomes of these psychedelic
experience characteristics and PF. Further research should continue to investigate how music
operates within the psychedelic experience, as well as following the experience for those who
participate in psychedelic-assisted psychotherapy. Music can have important implications in the
psychedelic sessions participants undergo, guiding psychedelic experiences in producing both
positive and challenging experiences (Kaelen et al., 2018).
It may also be important for future research to investigate what psychedelics provide over
and above other techniques in its therapeutic potential. Aside from the psychedelic experience,
studies have investigated near death experiences and have found similarities with mystical
experiences (Greyson, 2014), ego-dissolution (Martial et al., 2021), and spiritual transformation
(Greyson & Khanna, 2014). Meditation combined with surrendering at the start of the meditative
session has also been found to lead to mystical experiences and positive emotional outcomes
(Russ & Elliott, 2017). As previously mentioned, certain types of therapy such as ACT, is
designed to enhance psychological flexibility, and one way is through patients perceiving
alternative thoughts and emotions for circumstances and feelings in their life. As described by
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Yaden et al. (2017), there is a spectrum for self-transcendent experiences (i.e., transient mental
states encompassing decreased self-salience and increased connectedness). While certain
methods and activities such as deep meditation, intensive breathwork, or even viewing a
sunrise/sunset from the top of a mountain might induce awe on the lower side of this spectrum, a
psychedelic session may produce awe experiences that fall on the higher side of the spectrum,
likely due to the intensity, depth, duration, and onset by which these psychedelic experiences
occur. This awe on the higher side of the self-transcendent experience spectrum might allow for
feelings such as that the issues one faces are insignificant and unimportant in the grand scheme
of things. Above and beyond these aforementioned methods and perhaps others for potentially
enhancing PF and other positive outcomes, the psychedelic experience may provide a more rapid
onset and deeper positive outcomes. Future research should explore whether PF and other
positive outcomes (e.g., well-being, openness, mindfulness, optimism) are the same or
differentiate based on the method used or experience had for attaining the outcomes, and
additionally, whether sustained practice of methods such as meditation exceed the positive
outcomes that can be attained from psychedelic use.
Conclusion
The current study aimed to fill gaps in the literature on associations with psychological
flexibility among classic psychedelic users by investigating various characteristics of the
psychedelic experience including self-perceived meaningfulness of one’s intention, feelings of
comfort/safety during the experience, decentering, the mystical experience, ego-dissolution, and
insight. The first hypothesis investigated potential associations that feelings of comfort/safety
and intention might have with characteristics of the psychedelic experience. Results revealed that
both comfort/safety during the experience and intention were positively associated with
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decentering. Additionally, comfort/safety during the experience was associated with mystical
experiences, whereas intention was associated with insight and psychological flexibility. The
second hypothesis investigated potential associations that psychological flexibility might have
with decentering, mystical experiences, ego-dissolution, and insight. Decentering was the only
hypothesized variable to be significant. Throughout both hypotheses, associations were also
found for previous psychedelic experience and religious salience.
Although the current study did not investigate causation, it may be that a directional
relationship exists between certain variables. Feelings of comfort/safety along with perceived
meaningful intention could lead to decentering. Decentering without resistance to one's thoughts
and feelings, in turn, could lead to mystical experiences, ego-dissolution, and insight. Working in
union to assist in the process of self-reflection and perceiving alternative perspectives of
thoughts and emotions, these characteristics of the psychedelic experience may predict
psychological flexibility. It is important to note that previous psychedelic experience and
religious salience may also impact the effect on psychological flexibility.
These results filled gaps in the literature by being among the first studies to show an
association between feelings of comfort/safety and intention with decentering, which is a
variable that has not received much empirical attention in the psychedelic research field.
Additionally, the current study suggests that lifetime psychedelic use and religious salience may
play an important role in psychological flexibility and its potential predictors. These two
variables, especially religious salience, have also not received much attention in the field of
psychedelic research, which is unfortunate considering reports that psychedelics facilitate
personal and spiritual meaning in one’s life (R. R. Griffiths et al., 2019, 2008) as well as
improvements in well-being (Mans et al., 2021). To further clarify predictors of psychological
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flexibility, future research should investigate these characteristics of the psychedelic experience
through longitudinal studies, and studies with larger sample sizes. Future research may also want
to explore any impacts of previous psychedelic use and religious salience within a potential
directional relationship using a larger sample.
Although classic psychedelics are viewed as schedule one (i.e., no accepted medical
benefits, lack of accepted safety under medical supervision, high potential for abuse) within the
United States and are illegal throughout numerous countries, psychedelic research has seen a
revival in the past decade, with both cross-sectional and random-control trial studies suggesting
positive health outcomes such as addiction recovery, reduced post-traumatic stress symptoms,
spiritual growth, and increased positive outlooks on life. Future research should continue to
explore components of the experience from fields of psychology, neuroscience, and religion and
spirituality. By doing so, a larger picture can be developed to help understand and facilitate longlasting positive change.
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Figure 2a.
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Figure 2b.
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Table 1
Demographic Characteristics
Sample Characteristics

N
164

Valid %

%

Male
Female
Non-Binary
A gender not specified
Did not answer

104
57
7
2
257

61.2%
33.5%
4.1%
1.2%

24.4%
13.3%
1.6%
0.5%
60.2%

White/Caucasian American/European American
Other
Latino/a/x, Hispanic
Asian, Southeast Asian or Pacific Islander
African American
Middle Eastern
Black/Caribbean, West Indian
Did not answer

126
25
9
5
2
2
1
257

74.1%
14.7%
5.3%
2.9%
1.2%
1.2%
0.6%

29.5%
5.9%
2.1%
1.2%
0.5%
0.5%
0.2%
60.2%

Heterosexual or Straight
Bisexual
An orientation not listed
Queer
Pansexual
Heteroflexible
Gay
Lesbian

118
37
5
3
2
2
2
1

69.4%
21.8%
2.9%
1.8%
1.2%
1.2%
1.2%
0.6%

Did not answer

257

27.6%
8.7%
1.2%
0.7%
0.5%
0.5%
0.5%
0.2%
60.2%

Age
Gender

Race

Sexual Orientation

M (SD)
31 (11.4)
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N

Valid %

%

1

0.6%

0.2%
5.4%

Education Level
Less than 12 years of education
Pre-university educational completion or equivalent (e.g., in the
U.S., the term is High School/GED)
Some university classes or no degree
Technical or trade/vocational school
Associate’s Degree
Bachelor’s Degree
Master’s Degree
PhD or other Professional Degree (PsyD, MD, JD, DVM, etc.)
Did not answer

23

13.7%

47
17
14
40
17
9
259

28.0%
10.1%
8.3%
23.8%
10.1%
5.4%

11%
4%
3.3%
9.4%
4%
2.1%
60.7%

North America
Europe
Australia
Central America
South America
Asia
Pacific Islands
Did not answer

135
26
5
1
1
1
1
257

79.4%
15.3%
2.9%
0.6%
0.6%
0.6%
0.6%

31.6%
6.1%
1.2%
0.2%
0.2%
0.2%
0.2%
60.2%

24,999 or lower
25,000 – 49,999
50,000 – 74,999
75,000 – 99,000
100,000 or greater
Unknown
Did not answer

37
36
21
16
31
7
279

25%
24.3%
14.2%
10.8%
20.9%
4.7%

8.7%
8.4%
4.9%
3.7%
7.3%
1.6%
65.3%

Residence

Income Before Taxes
(Converted to USD)

M (SD)

Psychedelic Use and Psychological Flexibility
Sample Characteristics

96
N

Valid %

%

Not currently affiliated
Other
Christian or Protestant (e.g., Baptist, Presbyterian, Lutheran, etc.)
Buddhist
Catholic
Jewish
Pantheist
Agnostic
Muslim
Hindu
Taoist
Did not answer

102
31
12
8
6
2
2
2
1
1
1
259

60.7%
18.5%
7.1%
4.8%
3.6%
1.2%
1.2%
1.2%
0.6%
0.6%
0.6%

23.9%
7.3%
2.8%
1.9%
1.4%
0.5%
0.5%
0.5%
0.2%
0.2%
0.2%
60.7%

Yes
No
Did not answer

71
49
307

59.2%
40.8%

16.6%
11.5%
71.9%

Spiritual
Spiritual & Agnostic
Spiritual, Agnostic, & Atheistic
Atheistic
Agnostic
Agnostic & Atheistic
Spiritual & Atheistic
Neither Spiritual, Agnostic, & Atheistic
Did not answer

51
43
19
15
14
13
9
6
257

30%
25.3%
11.2%
8.8%
8.2%
7.6%
5.3%
3.5%

11.9%
10.1%
4.4%
3.5%
3.3%
3%
2.1%
1.4%
60.2%

M (SD)

Current Religious Affiliation

Previous Religious Affiliation

Religious Identification

Religious Salience
165
18.8 (10.5)
Note. Percentage out of N of 427. Cases with more than one racial identity or current religious affiliation were categorized into ‘other’.
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Table 2
Descriptive Statistics of Main Study Measures
M

SD

Scale Range

Actual Range

Skewness

Kurtosis

Statistic.

Std. Error

Statistic.

Std. Error

Psychological Flexibility

110.90

15.41

20 – 140

50 – 138

-1.11

.173

2.09

.345

Decentering

45.14

8.92

13 – 65

21 – 63

-.45

.155

-.19

.309

Mystical Experiences

97.48

29.77

0 – 135

3 – 135

-1.08

.163

.73

.324

Ego-Dissolution

531.82

190.02

0 – 800

0 – 800

-.64

.18

-.25

.358

Insight

89.02

35.76

0 - 140

0 – 140

-.75

.184

-.12

.366
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Table 3
Consumption Characteristics
Sample Characteristics

N

Valid %

%

1 time
2-4 times
5-10 times
10+ times
Did not answer

23
70
94
232
8

5.5%
16.7%
22.4%
55.4%

5.4%
16.4%
22%
54.3%
1.9%

LSD (Lysergic Acid Diethylamide)
Psilocybin (e.g., Psilocybin Mushrooms)
Ayahuasca
N,N-DMT, 5-Me0-DMT
Mescaline (e.g., Peyote, San Pedro)
Did not answer

118
104
22
20
2
161

44.4%
39.1%
8.3%
7.5%
0.8%

27.6%
24.4%
5.2%
4.7%
0.5%
37.7%

Low
Moderate
Moderately High
High
Did not answer

11
97
98
57
164

4.2%
36.9%
37.3%
21.7%

2.6%
22.7%
23%
13.3%
38.4%

Oral
Sublingual
Smoked/Vaporized
Did not answer

214
29
19
165

81.7%
11.1%
7.3%

50.1%
6.8%
4.4%
38.6%

Classic Psychedelic Experiences

Substance

Dose Characterization

Route of Administration
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Sample Characteristics
Under Influence of other Substances
No
Yes
Did not answer
Presence of Music
Yes
No
Did not answer

N

Valid %

%

164
96
167

63.1%
36.9%

38.4%
22.5%
39.1%

223
34
170

86.8%
13.2%

52.2%
8%
39.8%

Less than 1 Hour
1 – 3 Hours
3 – 5 Hours
More than 5 Hours
Unable to Recall
Did not answer

39
57
52
66
16
197

17%
24.8%
22.6%
28.7%
7%

9.1%
13.3%
12.2%
15.5%
3.7%
46.1%

Beneficial/Positive
Neutral
Detrimental/Negative
Beneficial/Positive, Neutral
Beneficial/Positive,
Detrimental/Negative
Beneficial/Positive, Neutral,
Detrimental/Negative
Did not answer

139
45
7
10

65.3%
21.1%
3.3%
4.7%

8

3.8%

32.6%
10.5%
1.6%
2.3%
1.9%

4

1.9%

Presence of Music – Length of Time

Musical Guidance

214

0.9%
50.1%
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N

Valid %

%

Time Since Experience
1 Day - 1 Week
28
11.3%
6.6%
1 Week - 1 Month
27
10.9%
6.3%
1 – 6 Months
64
25.8%
15%
6 Months – 1 Year
42
16.9%
9.8%
1 – 2 Years
32
12.9%
7.5%
Over 2 Years
55
22.2%
12.9%
Did not answer
179
41.9%
Note. Percentage out of N of 427. Under influence of other substances excludes Caffeine and Nicotine. Time since experience reported
as of participant survey completion.
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Table 4
Correlation Coefficients for Study Variables and Covariates
1

2

3

4

5

6

7

8

1. Age
2. Edu.

.327**
(162)

3. Inc.

.456**
(135)

.298**
(140)

4. Exp.

.273**
(164)

0.0
(168)

.196*
(141)

5. Dose

.211**
(164)

0.0
(168)

0.0
(141)

.404**
(263)

6. RS

.160*
(159)

0.0
(163)

0.0
(137)

0.1
(165)

0.1
(165)

7. Int.

.212**
(148)

0.1
(150)

0.0
(125)

0.1
(221)

0.1
(221)

.332**
(147)

8. CSI

0.1
(164)

0.0
(168)

0.0
(141)

0.1
(258)

0.1
(257)

0.0
(165)

0.0
(221)

9. CSD

0.1
(162)

-0.1
(166)

0.1
(140)

0.1
(254)

-.148*
(253)

0.0
(163)

0.0
(219)

.207**
(253)

9

10

11

12

13
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10. PF

.162*
(154)

0.1
(157)

.321**
(133)

.306**
(197)

0.1
(197)

.266** .291**
(154)
(175)

.182*
(197)

.170*
(194)

11. EQ

0.1
(161)

0.1
(165)

.180*
(138)

.286**
(247)

.192**
(247)

.295** .263**
(162)
(213)

.126*
(247)

.208**
(243)

.576**
(194)

12. ME

0.1
(158)

-0.1
(162)

0.0
(137)

.349**
(224)

.348**
(224)

.333** .247**
(159)
(194)

0.1
(224)

.147*
(220)

.213**
(191)

.299**
(222)

13. ED

0.0
(134)

-0.1
(135)

0.0
(115)

.271**
(182)

.342**
(182)

.226**
(132)

.154*
(182)

0.1
(180)

.179*
(160)

.248** .690**
(179)
(177)

0.1
(160)

14. Ins.

0.1
-.169*
-0.1
.365** .168* .335** .300**
0.1
0.0
.189* .211** .675** .333**
(151)
(156)
(131)
(174)
(174)
(154)
(154)
(174)
(171)
(162)
(171)
(170)
(141)
Note. * p < 0.05 ** p < 0.01; (2-Tailed). N values are listed in parentheses beneath correlations. Pairwise deletions were used.
Left Column Abbreviations. 1: Age; 2: Education Level; 3: Income; 4: Number of Previous Psychedelic Experiences; 5: Dose
Characterization; 6: Religious Salience; 7: Intention; 8: Comfort/Safety going into the Experience; 9: Comfort/Safety during the
Experience; 10: Psychological Flexibility; 11: Decentering; 12: ME = Mystical Experiences; 13: ED= Ego Dissolution; 14: Insight
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Table 5
Hierarchical Regression – The Role of Comfort/Safety during the Psychedelic Experience and
Intention on Psychological Flexibility
Variables

B

SE

101.22

3.94

Age

.03

.13

Income

3.20

.99

94.86

4.21

Age

-.06

.13

Income

3.61

Religious Salience

β

t

p

25.71

<.001

.02

.20

.844

.31

3.25

.002

22.51

<.001

-.05

-.47

.637

.95

.35

.38

<.001

.42

.12

.29

3.41

<.001

72.83

7.55

9.65

<.001

Age

-.16

.13

-.117

-1.26

.209

Income

3.48

.92

.34

3.77

<.001

Religious Salience

.39

.12

.26

3.22

.002

Number of Psychedelic Experiences

3.71

1.37

.22

2.71

.008

Comfort/Safety entering Experience

1.30

.64

.16

2.04

.044

R2

Model 1
Constant

.089

Model 2
Constant

.162

Model 3
Constant

.227
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Model 4
Constant

68.02

8.14

8.36

<.001

Age

-.17

.13

-.13

-1.35

.180

Income

3.41

.92

.33

3.71

<.001

Religious Salience

.40

.12

.27

3.32

.001

Number of Psychedelic Experiences

3.69

1.37

.22

2.70

.008

Comfort/Safety entering Experience

1.11

.65

.14

1.71

.091

Comfort/Safety during Experience

.85

.56

.12

1.52

.130

63.31

8.07

7.85

<.001

Age

-.24

.12

-.17

-1.90

.060

Income

3.68

.90

.36

4.11

<.001

Religious Salience

.29

.12

.20

2.43

.017

Number of Psychedelic Experiences

3.55

1.33

.21

2.68

.009

Comfort/Safety entering Experience

1.10

.63

.14

1.76

.082

Comfort/Safety during Experience

.83

.54

.12

1.52

.131

Intention

1.25

.43

.24

2.88

.005

.24

Model 5
Constant

.28

Note. Adjusted R2 was used to determine contribution. Model 1 summary: [F (2, 122) = 7.048, p
= .001, R2 = .09]; Model 2 summary: [F (3, 121) = 8.973, p < .001, R2 = .16]; Model 3
summary: [F (5, 119) = 8.267, p < .001, R2 = .23]; Model 4 summary: [F (6, 118) = 7.353, p <
.001, R2 = .24]; Model 5 summary: [F (7, 117) = 7.877, p < .001, R2 = .28]. (Total n = 124)
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Table 6
Hierarchical Regression – The Role of Comfort/Safety during the Psychedelic Experience and
Intention on Decentering
Variables

B

SE

40.41

1.46

.25

.07

27.52

4.16

Religious Salience

.22

.07

Number of Psychedelic Experiences

2.36

Comfort/Safety entering Experience

β

t

p

27.76

<.001

3.72

<.001

6.61

<.001

.26

3.36

.001

.74

.25

3.17

.002

.43

.36

.09

1.20

.234

22.92

4.47

5.12

<.001

Religious Salience

.23

.07

.27

3.55

<.001

Number of Psychedelic Experiences

2.29

.73

.24

3.13

.002

Comfort/Safety entering Experience

.24

.36

.05

.67

.503

Comfort/Safety during Experience

.78

.31

.20

2.52

.013

21.00

4.53

4.64

<.001

R2

Model 1
Constant
Religious Salience

.30

.081

Model 2
Constant

.141

Model 3
Constant

Model 4
Constant

.172
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Religious Salience

.19

.07

.22

2.74

.007

Number of Psychedelic Experiences

2.19

.73

.23

3.02

.003

Comfort/Safety entering Experience

.23

.35

.05

.64

.527

Comfort/Safety during Experience

.77

.31

.19

2.50

.013

Intention

.49

.24

.16

2.02

.045

.190

Note. Adjusted R2 was used to determine contribution. Model 1 summary: [F (1, 145) = 13.812,
p < .001, R2 = .08]; Model 2 summary: [F (3, 143) = 8.993, p < .001, R2 = .14]; Model 3
summary: [F (4, 142) = 8.591, p < .001, R2 = .17]; Model 4 summary: [F (5, 141) = 7.841, p <
.001, R2 = .19]. (Total n = 146)
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Table 7
Hierarchical Regression – The Role of Comfort/Safety during the Psychedelic Experience and
Intention on Mystical Experiences
Variables

B

SE

79.65

4.79

.95

.22

23.32

13.38

Religious Salience

.69

.22

Number of Psychedelic Experiences

6.30

Comfort/Safety entering Experience

β

R2

t

p

16.63

<.001

4.26

<.001 .105

1.74

.083

.24

3.13

.002

2.54

.20

2.47

.015

1.25

1.12

.08

1.11

.267

Dose Characterization

8.29

2.78

.23

2.98

.003

LSD

-1.53

4.75

-.03

-.32

.749

DMT

18.05

8.60

.16

2.10

.038

Ayahuasca

10.98

8.37

.10

1.31

.192

Constant

8.54

14.71

.58

.562

Religious Salience

.72

.22

.25

3.34

.001

Number of Psychedelic Experiences

5.62

2.53

.18

2.23

.028

Comfort/Safety entering Experience

.63

1.14

.04

.56

.580

Model 1
Constant
Religious Salience

.33

Model 2
Constant

Model 3

.258
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Dose Characterization

9.63

2.81

.27

3.43

<.001

LSD

-.73

4.69

-.01

-.16

.877

DMT

16.27

8.51

.14

1.91

.058

Ayahuasca

11.03

8.25

.10

1.34

.184

Comfort/Safety during Experience

2.25

.99

.17

2.27

.025

Constant

4.34

15.01

.29

.773

Religious Salience

.65

.22

.23

2.90

.004

Number of Psychedelic Experiences

5.45

2.52

.17

2.16

.032

Comfort/Safety entering Experience

.60

1.14

.04

.53

.597

Dose Characterization

9.37

2.81

.26

3.34

.001

LSD

.30

4.75

.01

.06

.950

DMT

16.74

8.50

.15

1.97

.051

Ayahuasca

10.49

8.24

.10

1.27

.205

Comfort/Safety during Experience

2.21

.99

.17

2.24

.027

Intention

1.02

.77

.10

1.32

.190

.280

Model 4

.283

Note. Adjusted R2 was used to determine contribution. Model 1 summary: [F (1, 145) = 18.102,
p < .001, R2 = .11]; Model 2 summary: [F (7, 139) = 8.259, p < .001, R2 = .26]; Model 3
summary: [F (8, 138) = 8.083, p < .001, R2 = .28]; Model 4 summary: [F (9, 137) = 7.416, p <
.001, R2 = .28]. (Total n = 146)
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Table 8
Hierarchical Regression – The Role of Comfort/Safety during the Psychedelic Experience and
Intention on Ego-Dissolution
Variables

B

SE

454.77

33.37

4.10

1.55

101.71

94.77

Religious Salience

3.40

1.47

Number of Psychedelic Experiences

26.57

Dose Characterization
Comfort/Safety entering Experience

β

t

p

13.63

<.001

2.64

.009

1.07

.285

.19

2.31

.022

18.00

.13

1.48

.142

60.69

19.92

.27

3.05

.003

10.77

7.94

.11

1.36

.177

Constant

31.24

104.94

.30

.766

Religious Salience

3.51

1.46

.19

2.40

.018

Number of Psychedelic Experiences

23.33

18.03

.11

1.29

.198

Dose Characterization

66.91

20.23

.30

3.31

.001

Comfort/Safety entering Experience

8.03

8.09

.08

.99

.323

Comfort/Safety during Experience

10.86

7.11

.13

1.53

.129

R2

Model 1
Constant
Religious Salience

.23

.044

Model 2
Constant

.160

Model 3

.169
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Model 4
Constant

44.81

106.96

.42

.676

Religious Salience

3.86

1.55

.21

2.49

.014

Number of Psychedelic Experiences

23.71

18.08

.12

1.31

.192

Dose Characterization

67.96

20.33

.30

3.34

.001

Comfort/Safety entering Experience

8.11

8.11

.08

1.00

.319

Comfort/Safety during Experience

11.05

7.13

.13

1.55

.123

Intention

-3.84

5.53

-.06

-.70

.488

.165

Note. Adjusted R2 was used to determine contribution. Model 1 summary: [F (1, 130) = 6.968, p
= .009, R2 = .04]; Model 2 summary: [F (4, 127) = 7.233, p < .001, R2 = .16]; Model 3
summary: [F (5, 126) = 6.315, p < .001, R2 = .17]; Model 4 summary: [F (6, 125) = 5.321, p <
.001, R2 = .17]. (Total n = 131)

Psychedelic Use and Psychological Flexibility

111

Table 9
Hierarchical Regression – The Role of Comfort/Safety during the Psychedelic Experience and
Intention on Insight
Variables

B

SE

103.66

7.60

-3.25

1.56

Constant

40.94

18.07

Education Level

-3.23

1.47

.69

Number of Psychedelic Experiences
Comfort/Safety entering Experience

β

t

p

13.64

<.001

-2.08

.039

2.27

.025

-.17

-2.21

.029

3.56

.02

.20

.846

13.72

3.20

.36

4.29

<.001

.26

1.42

.01

.19

.853

Constant

39.74

20.25

1.96

.052

Education Level

-3.21

1.48

-.17

-2.17

.032

.79

3.65

.02

.22

.828

Number of Psychedelic Experiences

13.67

3.23

.36

4.23

<.001

Comfort/Safety entering Experience

.22

1.46

.01

.15

.880

Comfort/Safety during Experience

.17

1.29

.01

.13

.894

R2

Model 1
Constant
Education Level

-.17

.022

Model 2

Dose Characterization

.139

Model 3

Dose Characterization

.133
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Model 4
Constant

25.97

19.74

1.32

.191

Education Level

-3.59

1.42

-.19

-2.53

.013

Dose Characterization

-.20

3.51

-.01

-.06

.956

Number of Psychedelic Experiences

12.94

3.10

.34

4.17

<.001

Comfort/Safety entering Experience

.07

1.40

.00

.05

.959

Comfort/Safety during Experience

.04

1.23

.00

.03

.973

Intention

3.37

.90

.28

3.73

<.001 .204

Note. Adjusted R2 was used to determine contribution. Model 1 summary: [F (1, 148) = 4.336, p
= .039, R2 = .02]; Model 2 summary: [F (4, 145) = 7.001, p < .001, R2 = .14]; Model 3
summary: [F (5, 144) = 5.567, p < .001, R2 = .13]; Model 4 summary: [F (6, 143) = 7.380, p <
.001, R2 = .20]. (Total n = 149)
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Table 10
Hierarchical Regression – Predicting Psychological Flexibility
Variables

B

SE

101.22

4.11

Age

.03

.14

Income

3.20

1.03

94.86

4.40

Age

-.06

.13

Income

3.61

Religious Salience

β

t

p

24.63

<.001

.02

.19

.851

.31

3.11

.002

21.56

<.001

-.05

-.45

.651

1.00

.35

3.62

<.001

.42

.13

.29

3.26

.001

81.66

6.54

12.49

<.001

Age

-.13

.13

-.09

-.96

.338

Income

3.36

.97

.33

3.45

<.001

Religious Salience

.39

.13

.26

3.08

.003

Number of Psychedelic Experiences

3.88

1.50

.23

2.67

.009

57.87

7.26

7.97

<.001

R2

Model 1
Constant

.088

Model 2
Constant

.160

Model 3
Constant

Model 4
Constant

.204
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Age

-.10

.12

-.07

-.82

.413

Income

2.62

.89

.26

2.95

.004

Religious Salience

.19

.12

.13

1.52

.131

Number of Psychedelic Experiences

1.94

1.44

.12

1.35

.179

Decentering

.81

.14

.47

5.63

<.001

Mystical Experiences

-.02

.07

-.03

-.23

.823

Ego-Dissolution

.00

.01

.01

.09

.927

Insight

.02

.05

.05

.42

.675

.369

Note. Adjusted R2 was used to determine contribution. Model 1 summary: [F (2, 112) = 6.471, p
= .002, R2 = .09]; Model 2 summary: [F (3, 111) = 8.231, p < .001, R2 = .16]; Model 3
summary: [F (4, 110) = 8.301, p < .001, R2 = .20]; Model 4 summary: [F (8, 106) = 9.329, p <
.001, R2 = .37]. (Total n = 114)
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Appendix A
General Use Questions
Instructions: Please answer the following questions to the best of your knowledge and as
honestly as you can. As a reminder, questions are voluntary, but answering all questions will
help the research team with keeping the survey as valid as possible.
1. How many times have you taken a classic psychedelic?
a. Never
b. 1 time
c. 2 – 4 times
d. 5 – 10 times
e. 10+ times
Instructions Two: If you have only taken a classic psychedelic one time before, answer the
following questions thinking about that experience. If you have used more than one time, answer
the following questions based on your most meaningful experience.
2. Which classic psychedelic was used?
a. LSD ((Lysergic Acid Diethylamide)
b. Psilocybin (i.e., Psilocybin Mushrooms)
c. Mescaline (i.e., Peyote, San Pedro)
d. DMT (N,N-dimethyltryptamine) or 5-MeO-DMT (5-methoxy-N,Ndimethyltryptamine)
e. Ayahuasca
3. What was the dose? If you do not know, answer "unknown".
4. How would you characterize the dose?
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a. Low
b. Moderate
c. Moderately High
d. High
5. What was the route of administration?
a. Oral
b. Sublingual
c. Smoked/Vaporized
d. Buccal
e. Intravenous
f. Intranasal
g. Other (Please Describe)
6. Were you under the influence of any other psychoactive substances (excluding caffeine
and nicotine)?
a. No
b. Yes (Please Describe)
7. How long has it been since the experience?
Instructions Three: The following questions will focus on the context of the psychedelic
session.
8. In what setting did you experience a majority of the psychedelic session? For example:
alone, with friends, with strangers, at a ritual or ceremony, in therapy, at a music/art
festival, concert, rave, party, etc. Please describe in as much detail as you remember.
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9. Did you have an intention prior to beginning the session? Do you recall this intention and
can you describe it here?
10. If you did have an intention prior to beginning the session, on a scale from 1 (Not
meaningful) to 10 (Very meaningful), please rate how meaningful the intention was to
you?
11. Please explain how you felt GOING INTO the experience.
12. On a scale from 1 (Not comfortable/safe at all) to 10 (Very comfortable/safe), please rate
how comfortable/safe you felt GOING INTO the experience.
13. On a scale from 1 (Not comfortable/safe at all) to 10 (Very comfortable/safe), please rate
how comfortable/safe you felt DURING the experience.
14. Was there music present during the experience?
a. Yes
b. No
15. If music was present during the experience, for how long would you say it was present?
a. Less than 1 hour
b. 1 – 3 hours
c. 3 – 5 hours
d. More than 5 hours
e. Unable to recall
16. If music was present during the experience, please rate your preference/liking of the
music during the experience on a scale from 1 (Did not prefer/like at all) to 10
(Preferred/liked very much).
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17. If music was present during the experience, do you feel that the music guided you
towards an experience you would describe as:
a. Beneficial or Positive (Please describe)
b. Neutral (No guiding effect)
c. Detrimental or Negative (Please describe)
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